Page last updated: 2024-08-26

fibrinogen and Cirrhosis, Liver

fibrinogen has been researched along with Cirrhosis, Liver in 256 studies

Research

Studies (256)

TimeframeStudies, this research(%)All Research%
pre-1990166 (64.84)18.7374
1990's23 (8.98)18.2507
2000's20 (7.81)29.6817
2010's33 (12.89)24.3611
2020's14 (5.47)2.80

Authors

AuthorsStudies
Adelmeijer, J; Bernal, W; Blasi, A; de Haas, RJ; Driever, EG; Fondevila, C; Gregory, S; Heaton, N; Kane, P; Lisman, T; Nagasami, C; Porte, RJ; van den Heuvel, MC; von Meijenfeldt, FA; Weisel, JW; Zen, Y1
Adelmeijer, J; Bernal, W; Blasi, A; Calvo, A; Corcoran, E; Fernandez, J; Lisman, T; Patel, VC; Spanke, ENHE; Stamouli, M; Zamalloa, A1
Enein, AA; Hussein, E1
Doyle, MB; Drobish, J; Jarasvaraparn, C; Khan, A; Kulkarni, S; Nadler, M; Rusch, C; Stoll, J1
Hidaka, H; Horie, R; Kubo, M; Kusano, C; Kuwana, M; Miyazaki, K; Satoh, T; Takiguchi, H; Tanaka, C; Uojima, H; Wada, N; Yokoyama, F1
Cai, X; Chen, J; Li, H; Tang, D; Zhang, P1
Han, M; Huang, J; Luo, X; Ning, Q; Tao, R; Wan, X; Wang, X; Xiao, F; Yan, W; Yuan, W1
Arévalo, AG; Blasi, A; Cendrós, JM; Colom, H; Montoro, B; Sabaté, A1
Adelmeijer, J; Bernal, W; Driever, EG; Koenderink, GH; Lisman, T; Muntz, I; Patel, V1
He, X; Li, Y; Pang, H1
Han, NK; Han, SC; Jeong, YJ; Jung, MG; Kim, SH; Lee, HJ; Lee, YJ; Lim, YB; Park, S; Park, SC; Son, Y1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Alsobrooks, JP; Budnick, IM; Davis, JPE; Intagliata, NM; Konkol, SB; Lau, CE; Lisman, T; Northup, PG; Stotts, MJ; Sundararaghavan, A1
Balsano, C; Capone, D; Citro, V; Gaudiano, G; Santini, SJ; Sinatti, G; Tarantino, G1
Jou, J; McMurry, HS; Shatzel, J1
Araj, E; De Simone, N; Laknezhad, S; Sarode, R; Usmani, A1
Govitrapong, P; Isarankura-Na-Ayudhya, C; Kitidee, K; Klosen, P; Pannengpetch, S; Wongchitrat, P1
Goya, T; Kato, M; Kohjima, M; Mutsuki, T; Ohe, M; Satoh, T; Yamashita, S1
Alnor, AB; Hvas, AM; Nybo, M; Vinholt, PJ1
Gong, Z; Yan, C; Yang, Q1
Bodini, G; Brunacci, M; Furnari, M; Giambruno, E; Giannini, EG; Plaz Torres, MC; Savarino, V; Zentilin, P1
Abdel Moneim, AE; Abdelhabib, S; Almeer, RS; El-Khadragy, MF1
Ibanez, IG; Klaus, F; Lohse, A; Meyer, B; Nagel, T; Wege, H1
Binh, MT; Hoan, NX; Meyer, CG; Quyen, DT; Quyet, D; Son, HA; Song, LH; Toan, NL; Van Ba, N; Van Luong, H; Van Tong, H; Velavan, TP1
Kurabekova, RM; Shevchenko, OP; Tsirulnikova, OM1
Bonnet, N; Clapuyt, P; Detaille, T; Dumitriu, D; Eeckhoudt, S; Helleputte, T; Hermans, C; Menten, R; Paul, J; Pirotte, T; Prégardien, C; Reding, R; Scheers, I; Smets, F; Sokal, E; Stéphenne, X; Varma, S; Veyckemans, F1
Biancofiore, G; Blasi, A; De Boer, MT; Franchini, M; Hartmann, M; Lisman, T; Liumbruno, GM; Porte, RJ; Saner, F; Senzolo, M; Werner, MJ1
Li, P; Li, Z; Lu, Y; Sun, D; Xu, Y; Zhang, X1
Caldwell, SH; Greenberg, CS; O'Leary, JG; Patton, HM1
Joshi, N; Kopec, AK; Luyendyk, JP; Towery, K; Williams, KJ1
Casals, G; Crespo, G; Forns, X; Jiménez, W; Marfà, S; Morales-Ruiz, M; Navasa, M; Reichenbach, V1
Chmura, A; Kosieradzki, M; Lągiewska, B; Lazowski, T; Nicińska, B; Pluta, J; Trzebicki, J; Wasiak, D1
Akyol, G; Callea, F; Dalgic, B; Francalanci, P; Giovannoni, I; Gonul, II; Sari, S; Yilmaz, G1
Chernousov, AF; Karpova, RV; Khorobrykh, TV1
de Ridder, GG; Lundblad, RL; Pizzo, SV1
Chen, J; Dong, J; Jiang, J; Lin, S; Shao, L; Wang, M; Weng, Z; Zhu, Y1
Chmura, A; Kołacz, M; Lisik, W; Nicińska, B; Pluta, J; Trzebicki, J; Łągiewska, B1
Liang, J; Song, W; Yang, C; Zhang, M; Zhao, Y; Zheng, W; Zheng, Y1
Ariëns, RA; Lisman, T1
Desborough, MJ; Jairath, V; Kahan, BC; Stanworth, SJ1
Gao, H; Jiang, L; Liu, C; Qin, R; Wang, M; Xiao, G; Yan, L; Yang, J; Ye, D; Zhang, H; Zhu, F1
Dai, M; Guan, WB; Ke, QS; Li, YM; Xie, HP; Yang, HZ; Zhang, SJ1
Janssen, HL; Jie, KS; Leebeek, FW; Pattynama, PM; Smalberg, JH; Spaander, MV; van Buuren, HR; van den Berg, B1
Bridle, KR; Clouston, AD; Crawford, DH; Fletcher, LM; Morgan, ML; Popa, C; Sobbe, AL1
Ha, KS; Jung, SH; Kim, YM; Kong, DH; Kwon, MH; Suh, IB1
Allen, K; Cantor, GH; Copple, BL; Guo, GL; Kassel, KM; Li, G; Luyendyk, JP1
Brzacki, V; Dinic-Radovic, V; Nagorni, A; Radovic, M; Ristic, L1
Gornjakovic, S; Mesihovic, R; Prohic, D; Saray, A; Vanis, N1
Abdo, AA; Gader, AG; Saja, MF; Sanai, FM; Shaikh, SA1
Imazeki, F; Kanai, F; Kuga, T; Nakajima, A; Nishimura, M; Noda, K; Nomura, F; Seimiya, M; Sogawa, K; Takizawa, H; Tomonaga, T; Tsutsumi, M; Umemura, H; Yokosuka, O; Yoneda, M1
Ghalib, R; Goss, J; Hassan, M; Levine, C; McClelland, T; Patt, YZ; Seu, P; Stribling, R1
BARBAGALLO-SANGIORGI, G; CAPUTO, A1
RETTENBACHER, F; SCHNEIDERBAUR, A1
MASETTO, I1
BELOVA, IV1
AUDITORE, JV; ENDE, N1
BAESSLER, KH; PRELLWITZ, W1
HALLEN, A; NILSSON, IM1
SAMAMA, M1
CROMWELL, S; MCFARLANE, AS; TODD, D1
AMRIS, A; AMRIS, CJ1
ALKJAERSIG, N; FLETCHER, AP; SHERRY, S1
SHARP, AA1
Anwar, MA; Rampling, MW1
Friedman, SL1
Bai, J; Cong, YL; Wei, YX; Yin, ZJ; Zhang, LW1
Bridle, K; Chang, P; Hung, DY; Roberts, MS; Siebert, GA1
Dhillon, AP; Difford, J; Etessami, N; Quaglia, A; Sim, R1
Başkol, M; Eser, B; Gürsoy, S; Güven, K; Ozbakir, O; Soyuer, I; Torun, E; Yücesoy, M; Yurci, A1
Akyol, G; Cindoruk, M; Degertekin, B; Ekinci, O; Karakan, T; Simsek, Z; Unal, S1
Göksel, V; Karaca, M; Yavuzgil, C1
Malé, PJ; Neerman-Arbez, M; Rougemont, AL; Rubbia-Brandt, L; Spahr, L1
Green, K; Mann, DA; Mann, J; Millward-Sadler, H; Oakley, F; Reynolds, G; Smart, DE; Weitzman, JB; Yaniv, M1
Ademoglu, E; Cefle, K; Gokkusu, C; Guler, K; Ozturk, S; Palanduz, S; Tamer, S; Vatansever, S1
Neerman-Arbez, M1
Knight, B; Lim, R; Olynyk, JK; Yeoh, GC1
Czakó, T; Papp, Z1
Cappellato, G; Dal Bo Zanon, R; Farinati, F; Girolami, A; Levi Minzi, S; Pengo, V1
Itakura, M; Iwamura, K; Kamiguchi, H; Katsunuma, T; Matsuzaki, S1
Neidhardt, B; Schricker, KT1
Drobnik, S; Dworniak, D; Tkacz, B1
Genth, K; Heene, DL1
Armstrong, DJ; Francis, JL1
Bernardi, M; Brocchi, E; Caletti, GC; Gasbarrini, G; Palareti, G; Pini, P1
Gollwitzer, R; Graeff, H; Hafter, R; Klaubert, E; Klaubert, W; von Hugo, R1
Alessandri, C; Balsano, F; Cordova, C; Ferro, D; Musca, A; Piromalli, A; Violi, F1
Comp, PC; Jacocks, RM; Radcliffe, R; Rubenstein, C1
Dudley, FJ; Gibson, PR; Jakobovits, AW; McInnes, IE; Salem, HH1
Hidai, K; Kamisasa, I; Sugiura, M; Wada, T; Yamanaka, M1
Harker, LA; Stein, SF1
Boyle, JM; Goodnough, LT; Heimburger, N; Saito, H1
Schipper, HG; ten Cate, JW1
Coccheri, S; Gervasoni, W; Mannucci, PM; Palareti, G; Poggi, M; Viganò, S1
Cuesta, B; Febres, R; Fernández, J; López Fernández, A; Narvaiza, MJ; Páramo, JA; Rocha, E1
Cristea, A; Cucuianu, MP; Missits, I; Roman, S1
Labastida-Muñoz, H; Landero de Ruiz, N; Ruiz-Argüelles, GJ; Ruiz-Reyes, G; Sánchez-Fernández, M1
Avventi, GL; Bonadiman, L; Doni, MG; Meduri, F; Vassanelli, P1
Egbring, R; Havemann, K; Klingemann, HG1
Giolma, JP; Kies, MS; Posch, JJ; Rubin, RN1
Bassi, N; Burra, P; De Silvestro, G; Nolli, ML; Patrassi, GM; Piccinni, P; Rossaro, L; Sartori, MT; Viero, M1
Hughes, RD; Izumi, S; Langley, PG; Pernambuco, JR; Williams, R1
de Maat, MP; Knot, EA; Nieuwenhuizen, W; Swart, GR; van Buuren, HR1
Pósán, E; Tornai, I; Udvardy, M1
Benhamou, JP; Bernuau, J; Crusiaux, A; Devaster, JM; Devière, J; Durand, F; Goldman, M; Le Moine, O1
Alessandri, C; Andreozzi, P; Basili, S; Cordova, C; Maurelli, M; Violi, F1
Amemiya, N; Endo, T; Kume, S1
Iwamoto, N; Kambayashi, J; Kawasaki, T; Mori, T; Ou, M; Sakon, M; Shiba, E; Shinozaki, K; Uemura, Y1
Brudasca, I; Cucuianu, M; Stancu, A; Trif, I1
Bird, AR; Kahn, D; Kirsch, RE; Kruskal, J; Robson, SC1
Anderson, SE; Ballmer, PE; Garlick, PJ; McNurlan, MA; Reichen, J; Sterchi, AB1
Ishida, H; Itakura, M; Matsuzaki, S; Shiraishi, K; Watanabe, M1
Alessandri, C; Andreozzi, P; Basili, S; Cara, D; Cordova, C; Maurelli, M; Vieri, M1
Erhard, J; Kabatnik, M; Peters, J; Scherer, R1
Cindoruk, M; Doğan, UB; Dumlu, S; Unal, S; Unlü, R1
Fehr, M; Mischke, R; Nolte, I; Pöhle, D; Schoon, HA1
Ben-Ari, Z; Burroughs, AK; Hutton, RA; Osman, E1
Agarwal, S; Joyner, KA; Swaim, MW1
Brennan, SO; Callea, F; Fabbretti, G; George, PM; Kudryk, B; Medicina, D1
Gabriel, DA; Roberts, HR; Stinchcombe, TE1
Ballard, HS; Marcus, AJ1
Damus, PS; Wallace, GA1
Astedt, B; Svanberg, L1
Abildgaard, U; Lie, M; Odegard, OR1
Bugat, R; Duffaut, M; Mignon-Conte, M; Orfila, C; Rumeau, JL; Suc, JM1
Jones, CE1
Heerklotz, I; Huyke, R; Vogel, G1
Braunstein, KM; Craig, WR; Eurenius, K; Hepfer, TW; Kinard, HB1
Dymock, IW; Green, G; Poller, L; Thomson, JM3
Lechner, K; Niessner, H; Thaler, E1
Johnson, PJ; White, Y; Williams, R; Woolf, IL1
Boggian, O; Coccheri, S; Dalmonte, PR; Palareti, G; Poggi, M1
Endo, O; Fukushima, K; Ikeuchi, T; Moroi, T; Nagakura, Y; Suyama, T; Tarao, K1
Harenberg, J; Hepp, G; Schmidt-Gayk, H1
Abe, T; Kazama, M; Miura, Y; Yasuda, J1
Hofmann, V; Mombelli, G; Straub, PW1
Azzam, ZA; El-Sawy, MA; Tawfik, S; Zeina, AA1
Brunswig, D; Klingemann, HG; Liehr, H1
Deykin, D; Weinstein, MJ1
Gurewich, V; Lipinska, I; Lipinski, B1
Khvatova, EA1
Civardi, E; Dettori, AG; Megha, A; Pini, M; Ponari, O; Poti, R1
Martinez, J; Palascak, JE1
Bisset, J; Camous, JP; Delmont, J; Faure, X; Rampal, P1
Abe, T; Kazama, M1
López Borrasca, A; Marin, J; Rocha, E1
Kochen, M; Leonhardt, H; Palme, G1
Dreyfus, B; Gorin, NC; Gouault, M; Rochan, H1
Bettigole, RE; Cohn, M; Coleman, M; Finlayson, N; Pasmantier, M; Sadula, D1
Glauser, FL; Levine, RI; Otis, PT; Smith, WR1
Lustermans, FA; Russel, MG; van Wersch, JW1
Brown-Castillo, J; Fujii, Y; Mammen, EF; Nakumura, R; Ozawa, T; Sugawa, C1
Hino, F; Katayama, M; Kato, I; Kurome, T; Uchida, H; Yamamoto, K1
De Maat, MP; Knot, EA; Kroneman, H; Nieuwenhuizen, W; Van Bergen, PF1
Shi, JZ; Wang, QM1
Cioni, G; Cristani, A; Grandi, S; Mussini, C; Pentore, R; Tizzanini, W; Ventura, E; Zagni, G; Zeneroli, ML1
Antico, S; Callegari, F; Cappellato, M; Girolami, A; Pengo, V; Ruffato, G1
Acca, MR; Balestrieri, A; Mameli, G; Mamusa, AM; Marongiu, F; Medda, A; Mulas, G; Tronci, MB1
Gotoh, M; Kambayashi, J; Kobayashi, K; Monden, M; Mori, T; Okamura, J; Sakon, M1
Berg, PL; Frick, B; Kalk, JF; Thiele, H1
Lai, EC; Ng, IO; Ng, M; Wu, PC1
Hartleb, M; Kacperek, T; Nowak, A1
Aronson, D; Carr, JM; McDonagh, J; vanDeWater, L1
Bellisola, G; Casaril, M; Corrocher, R; Gabrielli, GB; Miatto, O; Nicoli, N1
Boeri, G; Girolami, A; Patrassi, GM; Sartori, MT; Sgarabotto, D; Sturniolo, G1
Cusumano, S; Galimberti, M; Parachini, F; Petrella, V; Rigotti, T1
Anderlini, D; Cioni, G; Cristani, A; Di Pancrazio, L; Grandi, S; Minetto, G; Ventura, E; Vezzelli, C; Zeneroli, ML; Zirilli, E1
Ohkita, T; Tanaka, M1
Aznar, J; Berenguer, J; Estellés, A; Garrido, G; Regañón, E; Vila, V1
Haeberli, A; Mombelli, G; Monotti, R; Straub, PW1
Kobayashi, N; Maekawa, T; Saitoh, H1
Francis, JL; Ingram, AJ; Simmonds, VJ1
Gans, H; Matsumoto, K; Mori, K1
Astedt, B; Nilsson, IM; Svanberg, L1
Kotschy, M1
Génova, V; Georgief, Z1
Brunt, PW; Mowat, NA; Ogston, D1
Bungert, HJ; Leonhardt, H5
Brueckner, GG; Mainwaring, RL1
Biggs, JC; Chesterman, CN; Lord, RS1
Baele, G; De Vos, M; Van Nimmen, L1
Alkjaersig, N; Fisher, S; Fletcher, AP; Sherry, S1
Cremer-Elfrink, HM; den Ottolander, GJ; Leijnse, B1
Gurewich, V; Hawiger, J; Niewiarowski, S; Thomas, DP1
Bloch, KJ; Colman, RW; Myers, AR; Niewiarowski, S; Thomas, DP1
Johnson, AJ; Merskey, C1
Blatný, J; Fischerová, E; Pelikán, V; Seidlová, V1
Judkiewicz, L; Olszañska, T; Tomaszewska, L1
Boulle, J; Buffet, C; Conard, J; Levy, VG; Samama, M1
Mester, L; Soria, J; Szabados, L1
Ansari, A; Silvis, SE1
Aiach, M; Busy, MF; Chanrion, C; Durand, H; Guéroult, N; Justin-Besançon, L; Leclerc, M; Rogé, J1
Wardle, EN1
Brunswig, D; Grün, M; Liehr, H; Thiel, H1
Al'pidovskiĭ, VK; Primak, A; Vogel, ChL1
Thomas, DP1
Blomhoff, JP; Gjone, E; Ritland, S; Skrede, S1
Fischer, M; Gauss, P; Korp, W; Nobis, H; Schnack, B; Weissmann, A1
Kreuning, J; Veltkamp, JJ1
Bungert, HJ1
Arnaud, P; Berthoux, F; Dechavanne, M; Thouverez, JP; Viala, JJ1
Rö, JS1
Collen, D; Vermylen, J; Verstraete, M1
Lasch, HG1
Cattan, D; Chardon, E; Gouault-Heilmann, M; Sultan, C; Yvart, J1
Gandolfo, GM1
Pierce, LE1
Perron, L; Thuot, C2
Javid, JP; Lackner, H1
Baele, G; Barbier, F; de Weerdt, GA; van Outryve, M1
Kourilsky, O; Leroy, C; Peltier, AP1
Cucuianu, M; Popescu, TA; Vasile, V1
Ananchenko, VG; Zaĭtsev, VF1
Zetterqvist, E1
Coon, WW; Iob, VL1
Gormsen, J1
Buraschi, J; Sack, ES2
Brodsky, I; Kahn, SB; Petkov, G; Ross, EM1
Blombäck, M; Norén, I1
Hällén, J; Laurell, CB1
Askherkhanov, RP; Safarov, SIu1
Brody, JI1
Collen, D; Tytgat, GN; Verstraete, M2
Bungert, HJ; Leonhardt, H; Schmidt, H; von Wolff, C1
Bennett, NB; Ogston, CM; Ogston, D1
Bilski-Pasquier, G; Girard, ML; Samama, M; Soria, C; Soria, J; Yver, J1
Rakhimov, SI; Tadzhiev, KT1
Grossi, CE; Prytz, B; Rousselot, LM1
Mammen, E; Walt, AJ; Wilson, RF1
Cash, JD; Das, PC1
Gerhold, WM; Mandel, EE1
Gormsen, J; Laursen, B1
Cain, GD; Jones, EA; Mayer, G1
Brodsky, I; Kahn, SB; Petkov, G; Ross, EM; Siegel, NH1
Losowsky, MS; Walls, WD2
Iutanova, II; Loginov, AS1
Gugler, E; Tschäppeler, H1
Genton, E; Wolf, PS1
Takahama, T1
Götz, H; Moussazadeh, M; Reichel, H1
Ryzhkova, LA1
Dumont, AE; Shinowara, GY; Stutman, LJ1
Holzknecht, F; Wilflingseder, P1
Daniele, F; Gillardi, U; Rizzi, D1
Brodsky, I; Dennis, LH1
Hajjar, GC; Moser, KM1
Blombäck, B; Carlson, LA; Franzén, S; Zetterqvist, E1

Reviews

17 review(s) available for fibrinogen and Cirrhosis, Liver

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
The hemostatic and thrombotic complications of liver disease.
    European journal of haematology, 2021, Volume: 107, Issue:4

    Topics: Anticoagulants; Blood Platelets; Blood Transfusion; Fibrinogen; Hemostasis; Heparin, Low-Molecular-Weight; Humans; Liver Cirrhosis; Thrombosis; von Willebrand Factor

2021
[THE ROLE OF TRANSFORMING GROWTH FACTOR BETA 1 UNDER DISEASES OF LIVER].
    Klinicheskaia laboratornaia diagnostika, 2017, Volume: 62, Issue:3

    Topics: Cytokines; Fibrinogen; Hepatic Stellate Cells; Hepatocytes; Humans; Liver; Liver Cirrhosis; Signal Transduction; Th1 Cells; Transforming Growth Factor beta1

2017
AGA Clinical Practice Update: Coagulation in Cirrhosis.
    Gastroenterology, 2019, Volume: 157, Issue:1

    Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Transfusion; Factor Xa Inhibitors; Fibrinogen; Hematocrit; Heparin; Humans; International Normalized Ratio; Liver Cirrhosis; Plasma; Platelet Count; Portal Vein; Thrombelastography; Thrombocytopenia; Thrombophilia; Thrombopoietin; Transfusion Reaction; Venous Thrombosis

2019
Actions of thrombin in the interstitium.
    Journal of thrombosis and haemostasis : JTH, 2016, Volume: 14, Issue:1

    Topics: Animals; Blood Coagulation; Extracellular Matrix; Extracellular Space; Fibrin; Fibrinogen; Fibroblasts; Fibrosis; Hemostasis; Humans; Liver Cirrhosis; Mice; Platelet Aggregation; Prothrombin; Pulmonary Fibrosis; Signal Transduction; Thrombin

2016
Alterations in Fibrin Structure in Patients with Liver Diseases.
    Seminars in thrombosis and hemostasis, 2016, Volume: 42, Issue:4

    Topics: Fibrin; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Protein Processing, Post-Translational; Thrombosis

2016
[THE PHYSIOPATHOLOGY OF FIBRINOLYSIS AND ITS CLINICAL AND THERAPEUTIC APPLICATIONS].
    Transfusion, 1964, Volume: 7

    Topics: Blood Transfusion; Enzyme Inhibitors; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemostatics; Humans; Leukemia; Liver Cirrhosis; Male; Pathology; Physiology; Polycythemia Vera; Pregnancy; Pregnancy Complications; Pregnancy Complications, Hematologic; Prostatectomy; Prostatic Neoplasms; Prothrombin; Thrombin; Thromboplastin

1964
PATHOLOGICAL FIBRINOLYSIS.
    British medical bulletin, 1964, Volume: 20

    Topics: Aminocaproates; Aminocaproic Acid; Anticoagulants; Blood Coagulation Disorders; Blood Group Incompatibility; Deoxyribonuclease I; Drug Therapy; Female; Fibrinogen; Fibrinolysis; Heart, Artificial; Hematoma; Hematoma, Subdural; Humans; Leukemia; Liver Cirrhosis; Male; Menorrhagia; Peritoneum; Pleura; Postoperative Complications; Pregnancy; Pregnancy Complications; Prostatic Neoplasms; Snake Bites; Streptodornase and Streptokinase; Streptokinase; Thrombocytopenia; Urogenital System; Wounds and Injuries

1964
[Disorders of hemostasis in liver cirrhosis. 2. Therapy].
    Fortschritte der Medizin, 1982, May-13, Volume: 100, Issue:18

    Topics: Antithrombin III; Aprotinin; Blood Coagulation Disorders; Blood Transfusion; Disseminated Intravascular Coagulation; Erythrocyte Transfusion; Factor XIII; Fibrinogen; Heparin; Humans; Liver Cirrhosis; Platelet Transfusion; Prothrombin; Vitamin K

1982
The dysfibrinogenaemias.
    British journal of haematology, 2001, Volume: 114, Issue:2

    Topics: Afibrinogenemia; Blood Coagulation Tests; Carcinoma, Hepatocellular; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Liver Neoplasms; Mutation; Thrombosis

2001
[Hemostasis disorders in liver cirrhosis].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1973, May-01, Volume: 28, Issue:19

    Topics: Blood Coagulation Disorders; Blood Platelet Disorders; Blood Platelets; Factor IX; Factor VII; Factor XI; Factor XIII; Fibrinogen; Fibrinolysin; Humans; Hypersplenism; Liver; Liver Cirrhosis; Prothrombin Time

1973
Hemostatic problems in liver surgery.
    Scandinavian journal of gastroenterology. Supplement, 1973, Volume: 19

    Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Dogs; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Factor XIII; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Postoperative Complications; Prothrombin; Vitamin K Deficiency

1973
Intravascular coagulation in liver disease.
    Annual review of medicine, 1974, Volume: 25

    Topics: Animals; Blood Coagulation Factors; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disseminated Intravascular Coagulation; Ethanol; Fibrinogen; Half-Life; Hemostasis; Humans; Ligation; Liver; Liver Cirrhosis; Liver Diseases; Plasminogen; Portal Vein; Prothrombin

1974
[The liver and plasma coagulation factors. Pathophysiology].
    Thrombosis et diathesis haemorrhagica. Supplementum, 1973, Volume: 55

    Topics: Antithrombins; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Cholestasis; Disseminated Intravascular Coagulation; Esophageal and Gastric Varices; Factor IX; Factor V; Factor VIII; Factor XIII; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Liver Transplantation; Microcirculation; Transplantation, Homologous

1973
[Significance of thrombogenesis in the pathogenesis of arteriosclerosis (literature review)].
    Kardiologiia, 1967, Volume: 7, Issue:1

    Topics: Animals; Aorta; Arteriosclerosis; Blood Coagulation; Blood Coagulation Disorders; Blood Vessels; Endocrine Glands; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Heparin Antagonists; Hepatitis; Humans; Lipid Metabolism; Lipoprotein Lipase; Liver; Liver Cirrhosis; Stress, Physiological; Thrombin; Thrombosis; Triglycerides

1967
Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
    Acta physiologica Scandinavica. Supplementum, 1969, Volume: 325

    Topics: Aminocaproates; Animals; Anticoagulants; Antifibrinolytic Agents; Antigens; Aprotinin; Blood Cell Count; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Chromatography; Chromatography, Gel; Dogs; Epidermolysis Bullosa; Fibrinogen; Fibrinolysis; Hematocrit; Immunoelectrophoresis; Injections, Intravenous; Iodine Isotopes; Liver Cirrhosis; Peptides; Polycythemia Vera; Potassium Iodide; Thrombin; Thromboplastin; Thrombosis

1969
The liver and protein metabolism.
    Major problems in clinical surgery, 1964, Volume: 1

    Topics: Amino Acids; Blood Proteins; Chemical and Drug Induced Liver Injury; Cystine; Diet Therapy; Dietary Proteins; Fatty Liver; Fibrinogen; Flocculation Tests; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Necrosis; Protein Biosynthesis; Protein Deficiency; Proteins; Prothrombin Time; RNA; Serum Albumin; Serum Globulins; Thyroid Hormones

1964

Trials

6 trial(s) available for fibrinogen and Cirrhosis, Liver

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients.
    World journal of gastroenterology, 2008, Oct-21, Volume: 14, Issue:39

    Topics: Adult; Bilirubin; Blood Circulation; Blood Coagulation; Blood Coagulation Disorders; Female; Fibrinogen; Hepatitis B; Hepatitis B virus; Humans; Jaundice; Liver Cirrhosis; Male; Medicine, Chinese Traditional; Middle Aged; Prothrombin Time; Retrospective Studies; Treatment Outcome

2008
The coagulopathy of liver disease: does vitamin K help?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:1

    Topics: Adult; Aged; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Tests; Carcinoma, Hepatocellular; Factor VII; Female; Fibrinogen; Hemorrhagic Disorders; Hepatitis B, Chronic; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Protein C; Protein Precursors; Protein S; Prothrombin; Treatment Outcome; Vitamin K; Young Adult

2013
Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis.
    Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:5

    Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Female; Fibrinogen; Follow-Up Studies; Hemoglobins; Humans; Interleukin-11; L-Lactate Dehydrogenase; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Recombinant Proteins; Thrombocytopenia; Treatment Outcome

2003
Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis.
    Journal of hepatology, 1994, Volume: 20, Issue:6

    Topics: Adult; Aged; Bacterial Infections; Biomarkers; C-Reactive Protein; Fibrinogen; Follow-Up Studies; Humans; Interleukin-6; Liver Cirrhosis; Middle Aged; Prognosis; Time Factors; Tumor Necrosis Factor-alpha

1994
The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease.
    Intensive care medicine, 1997, Volume: 23, Issue:11

    Topics: Adult; Antithrombin III; Blood Coagulation; Chronic Disease; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Partial Thromboplastin Time; Prospective Studies; Prothrombin Time; Serine Proteinase Inhibitors

1997

Other Studies

234 other study(ies) available for fibrinogen and Cirrhosis, Liver

ArticleYear
Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus.
    Hepatology (Baltimore, Md.), 2022, Volume: 75, Issue:4

    Topics: Anticoagulants; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Portal Vein; Retrospective Studies; Thrombosis; Venous Thrombosis; von Willebrand Factor

2022
Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates.
    Liver international : official journal of the International Association for the Study of the Liver, 2022, Volume: 42, Issue:2

    Topics: Blood Coagulation; Blood Coagulation Factors; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Thrombosis

2022
Quality Assessment and Clinical Utility of Plasma Obtained Via Apheresis vs That Obtained from Whole Blood.
    Laboratory medicine, 2022, Sep-01, Volume: 53, Issue:5

    Topics: Blood Component Removal; Factor V; Fibrinogen; Humans; Liver Cirrhosis; Plasma; Purpura, Thrombotic Thrombocytopenic

2022
Characterization of Biomarkers of Hemostasis and Bleeding-Related Outcomes in Children With Cirrhosis.
    Journal of pediatric gastroenterology and nutrition, 2022, 10-01, Volume: 75, Issue:4

    Topics: Adult; Biomarkers; Child; Fibrinogen; Hemorrhage; Hemostasis; Humans; Liver Cirrhosis; Retrospective Studies

2022
B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis.
    Annals of hematology, 2022, Volume: 101, Issue:11

    Topics: Autoantibodies; B-Cell Activating Factor; Blood Platelets; Fibrinogen; Humans; Liver Cirrhosis; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia

2022
Evaluation of Serum FGL1 as Diagnostic Markers for HBV-Related Hepatocellular Carcinoma.
    Laboratory medicine, 2023, May-02, Volume: 54, Issue:3

    Topics: alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Fibrinogen; Hepatitis B virus; Humans; Liver Cirrhosis; Liver Neoplasms

2023
Fibrinogen-like protein 2 promotes proinflammatory macrophage polarization and mitochondrial dysfunction in liver fibrosis.
    International immunopharmacology, 2023, Volume: 117

    Topics: Fibrinogen; Fibrosis; Hepatitis B; Humans; Inflammation; Liver Cirrhosis; Macrophage Activation; Macrophages; Proto-Oncogene Proteins c-akt

2023
Population pharmacokinetic modelling of fibrinogen in patients with congenital or acquired-chronic or acute-hypofibrinogenaemia.
    British journal of clinical pharmacology, 2023, Volume: 89, Issue:9

    Topics: Afibrinogenemia; Blood Coagulation; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis

2023
Fibrin clots from patients with acute-on-chronic liver failure are weaker than those from healthy individuals and patients with sepsis without underlying liver disease.
    Journal of thrombosis and haemostasis : JTH, 2023, Volume: 21, Issue:10

    Topics: Acute-On-Chronic Liver Failure; Fibrin; Fibrinogen; Fibrinolysis; Fibrosis; Hemostatics; Humans; Liver Cirrhosis; Sepsis; Thrombosis

2023
A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2019, Volume: 30, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Hepatic Encephalopathy; Humans; Hypertension, Portal; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Predictive Value of Tests; Preoperative Period; Reference Values; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Treatment Outcome; Young Adult

2019
Plasma Fibrinogen-Like 1 as a Potential Biomarker for Radiation-Induced Liver Injury.
    Cells, 2019, 09-06, Volume: 8, Issue:9

    Topics: Animals; Apoptosis; Autophagy; Biomarkers; Cells, Cultured; Fibrinogen; Hepatocytes; Humans; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Radiation Injuries, Experimental; Radiation, Ionizing

2019
Transfusion with Cryoprecipitate for Very Low Fibrinogen Levels Does Not Affect Bleeding or Survival in Critically Ill Cirrhosis Patients.
    Thrombosis and haemostasis, 2021, Volume: 121, Issue:10

    Topics: Afibrinogenemia; Biomarkers; Blood Transfusion; Critical Illness; Down-Regulation; Esophageal and Gastric Varices; Factor VIII; Female; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Intensive Care Units; Liver Cirrhosis; Male; Middle Aged; Patient Admission; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome

2021
Copper concentrations are prevalently associated with antithrombin III, but also with prothrombin time and fibrinogen in patients with liver cirrhosis: A cross-sectional retrospective study.
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2021, Volume: 68

    Topics: Albumins; Antithrombin III; Blood Coagulation Factors; Copper; Cross-Sectional Studies; Fibrinogen; Hemostatics; Humans; Liver Cirrhosis; Prothrombin Time; Retrospective Studies

2021
Observed incidence of hypofibrinogenemia in cirrhotic patients.
    Liver international : official journal of the International Association for the Study of the Liver, 2021, Volume: 41, Issue:10

    Topics: Afibrinogenemia; Fibrinogen; Humans; Incidence; Liver Cirrhosis

2021
High-fat diet-induced plasma protein and liver changes in obese rats can be attenuated by melatonin supplementation.
    Nutrition research (New York, N.Y.), 2017, Volume: 42

    Topics: alpha 1-Antitrypsin; Animals; Biomarkers; Blood Glucose; Blood Proteins; Body Weight; Complement C4; Complement Factor B; Diet, High-Fat; Diet, High-Protein; Dietary Carbohydrates; Disease Models, Animal; Fatty Liver; Fibrinogen; Inflammation; Insulin; Liver; Liver Cirrhosis; Male; Mannose-Binding Lectin; Melatonin; Obesity; Plasminogen; Proteomics; Rats; Rats, Wistar

2017
Portal Vein Thrombosis Repeatedly Observed in a Cirrhotic Patient with Antiphospholipid Antibody Syndrome.
    Fukuoka igaku zasshi = Hukuoka acta medica, 2016, Volume: 107, Issue:10

    Topics: Antiphospholipid Syndrome; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Tomography, X-Ray Computed; Venous Thrombosis

2016
The primary haemostasis is more preserved in thrombocytopenic patients with liver cirrhosis than cancer.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2018, Volume: 29, Issue:3

    Topics: Adult; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Neoplasms; Partial Thromboplastin Time; Platelet Aggregation; Platelet Count; Thrombin; Thrombocytopenia

2018
Activation of Hepatic Stellate Cells During Liver Carcinogenesis Requires Fibrinogen/Integrin αvβ5 in Zebrafish.
    Neoplasia (New York, N.Y.), 2018, Volume: 20, Issue:5

    Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Disease Progression; Fibrinogen; Hepatic Stellate Cells; Hepatocytes; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Oncogenes; Receptors, Vitronectin; Signal Transduction; Zebrafish

2018
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients.
    Annals of hepatology, 2018, Jun-05, Volume: 17, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Coagulation; Down-Regulation; Endoscopy; Esophageal and Gastric Varices; Female; Fibrinogen; Gastrointestinal Hemorrhage; Humans; International Normalized Ratio; Ligation; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Postoperative Hemorrhage; Risk Assessment; Risk Factors; Thrombocytopenia; Time Factors; Treatment Outcome

2018
Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice.
    PloS one, 2018, Volume: 13, Issue:10

    Topics: Animals; Disease Models, Animal; Down-Regulation; Drug Administration Schedule; Fibrinogen; Gene Expression Regulation; Lipid Peroxidation; Liver Cirrhosis; Liver Function Tests; Male; Mice; NF-E2-Related Factor 2; Oxidative Stress; Plant Extracts; Plant Leaves; Schistosomiasis mansoni; Signal Transduction; Ziziphus

2018
Fast and facile analysis of glycosylation and phosphorylation of fibrinogen from human plasma-correlation with liver cancer and liver cirrhosis.
    Analytical and bioanalytical chemistry, 2018, Volume: 410, Issue:30

    Topics: Carcinoma, Hepatocellular; Fibrinogen; Glycosylation; Humans; Liver Cirrhosis; Liver Neoplasms; Phosphorylation; Protein Processing, Post-Translational; Reference Standards; Time Factors

2018
Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
    BMC infectious diseases, 2018, Nov-12, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Carcinoma, Hepatocellular; Case-Control Studies; Disease Progression; Female; Fibrinogen; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Solubility; Young Adult

2018
Novel insights into the assessment of risk of upper gastrointestinal bleeding in decompensated cirrhotic children.
    Pediatric transplantation, 2019, Volume: 23, Issue:4

    Topics: Blood Coagulation; Child; Child, Preschool; End Stage Liver Disease; Endoscopy; Esophageal and Gastric Varices; Female; Fibrinogen; Gastrointestinal Hemorrhage; Hemostasis; Humans; Hypertension, Portal; Infant; Liver Cirrhosis; Liver Transplantation; Male; Platelet Aggregation; Predictive Value of Tests; Prospective Studies; Risk Factors; Waiting Lists

2019
Perioperative hemostatic management in the cirrhotic patient: a position paper on behalf of the Liver Intensive Care Group of Europe (LICAGE).
    Minerva anestesiologica, 2019, Volume: 85, Issue:7

    Topics: Anemia; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Blood Loss, Surgical; Deamino Arginine Vasopressin; Elective Surgical Procedures; Europe; Factor VIIa; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Hemostatic Techniques; Hemostatics; Humans; Liver Cirrhosis; Perioperative Care; Plasma; Platelet Function Tests; Platelet Transfusion; Postoperative Hemorrhage; Recombinant Proteins

2019
A non-autonomous role of MKL1 in the activation of hepatic stellate cells.
    Biochimica et biophysica acta. Gene regulatory mechanisms, 2019, Volume: 1862, Issue:6

    Topics: Animals; Cells, Cultured; Connective Tissue Growth Factor; Fibrinogen; Glucose; HEK293 Cells; Hep G2 Cells; Hepatic Stellate Cells; Hepatocytes; Humans; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Models, Animal; RNA, Small Interfering; Smad3 Protein; Trans-Activators; Transcription Factor AP-1; Up-Regulation

2019
The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 349, Issue:3

    Topics: 1-Naphthylisothiocyanate; Animals; Antifibrinolytic Agents; Bile Duct Diseases; Collagen Type I; Disease Models, Animal; Fibrin; Fibrinogen; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Plasminogen Activator Inhibitor 1; Tranexamic Acid

2014
Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver disease.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Disease Progression; Female; Fibrinogen; Hep G2 Cells; Hepacivirus; Hepatitis C; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Middle Aged; Peptide Fragments

2014
The effects of in vitro hemodilution and fibrinogen concentrate substitution on thromboelastometry analysis in patients qualified for liver transplantation - preliminary results.
    Transplantation proceedings, 2014, Volume: 46, Issue:8

    Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Case-Control Studies; Female; Fibrinogen; Hemodilution; Hemorrhage; Hemostasis; Hemostatics; Humans; Hydroxyethyl Starch Derivatives; In Vitro Techniques; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prospective Studies; Thrombelastography

2014
Fibrinogen storage disease and cirrhosis associated with hypobetalipoproteinemia owing to fibrinogen Aguadilla in a Turkish child.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:12

    Topics: Afibrinogenemia; Carbamazepine; Child, Preschool; Cholagogues and Choleretics; Cytochrome P-450 CYP3A Inducers; Female; Fibrinogen; Humans; Hypobetalipoproteinemias; Liver; Liver Cirrhosis; Mutation, Missense; Treatment Outcome; Ursodeoxycholic Acid

2015
[Liver tissue regeneration under the influence of cryoprecipitate and alloplant].
    Khirurgiia, 2015, Issue:7

    Topics: Adolescent; Adult; Aged; Allografts; Cell- and Tissue-Based Therapy; Factor VIII; Female; Fibrinogen; Fibronectins; Humans; Liver Cirrhosis; Liver Regeneration; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult

2015
Hemorrhagic Complications Following Abdominal Paracentesis in Acute on Chronic Liver Failure: A Propensity Score Analysis.
    Medicine, 2015, Volume: 94, Issue:49

    Topics: Acute-On-Chronic Liver Failure; Adult; Female; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Paracentesis; Prognosis; Propensity Score; Prothrombin; Retrospective Studies; Risk Factors

2015
Is Hydroxyethyl Starch Irrelevant to Hemostasis in Patients Undergoing Liver Transplantation?--In vitro Analysis Based on Thromboelastometry.
    Annals of transplantation, 2015, Dec-17, Volume: 20

    Topics: Blood Coagulation Tests; Blood Loss, Surgical; Cohort Studies; Female; Fibrinogen; Fluid Therapy; Follow-Up Studies; Hemodilution; Hemostasis; Hemostatic Techniques; Humans; Hydroxyethyl Starch Derivatives; In Vitro Techniques; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Risk Assessment; Thrombelastography; Treatment Outcome

2015
[Hepatopulmonary syndrome-related changes in D-dimer, prothrombin time, fibrinogen, CD4 and CD8 in a rat model system].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2015, Volume: 23, Issue:12

    Topics: Animals; CD4 Antigens; CD4-CD8 Ratio; CD8 Antigens; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatopulmonary Syndrome; Liver Cirrhosis; Lung; Male; Prothrombin Time; Rats; Rats, Sprague-Dawley

2015
Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding.
    Hepatology (Baltimore, Md.), 2017, Volume: 65, Issue:3

    Topics: Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis

2017
Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.
    Oncotarget, 2017, Jan-17, Volume: 8, Issue:3

    Topics: Adult; Area Under Curve; Bilirubin; Biomarkers; Carcinoma, Hepatocellular; Female; Fibrinogen; Hepatectomy; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Platelet Count; Preoperative Period; Prospective Studies; Prothrombin; Regression Analysis; Retrospective Studies

2017
Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis.
    Thrombosis and haemostasis, 2008, Volume: 100, Issue:6

    Topics: Adult; Budd-Chiari Syndrome; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Patient Selection; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Retrospective Studies; Risk Assessment; Splanchnic Circulation; Thrombolytic Therapy; Treatment Outcome; Vascular Patency; Venous Thrombosis

2008
Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2009, Volume: 15, Issue:10

    Topics: Animals; Cell Differentiation; Cell Proliferation; Epithelium; Fibrinogen; Fibrosis; Immunosuppressive Agents; Liver; Liver Cirrhosis; Male; Mesoderm; Models, Biological; Rats; Rats, Wistar; Sirolimus; Stem Cells

2009
Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma.
    Analytical chemistry, 2011, Mar-15, Volume: 83, Issue:6

    Topics: Amines; Biomarkers, Tumor; Biotin; Blood Specimen Collection; Carcinoma, Hepatocellular; Factor XIII; Fibrinogen; Hepatitis; Humans; Immobilized Proteins; Isoniazid; Limit of Detection; Liver Cirrhosis; Liver Neoplasms; Protein Array Analysis; Reproducibility of Results; Serologic Tests; Time Factors

2011
Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.
    The American journal of pathology, 2011, Volume: 178, Issue:3

    Topics: 1-Naphthylisothiocyanate; Afibrinogenemia; Aged; Animals; Bile Ducts; Cholestasis; Chronic Disease; Collagen; Diet; Disease Models, Animal; Early Growth Response Protein 1; Feeding Behavior; Female; Fibrin; Fibrinogen; Gene Expression Regulation; Humans; Hyperplasia; Inflammation; Liver; Liver Cirrhosis; Male; Mice; Middle Aged; Neutrophils; Xenobiotics

2011
Importance of certain pro-inflammatory indices in patients with liver cirrhosis and bacterial infection on prognosis and course of the disease.
    Medicinski arhiv, 2012, Volume: 66, Issue:1

    Topics: Bacterial Infections; Biomarkers; Blood Sedimentation; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Prognosis; Survival Rate

2012
Clinical significance of haemostatic tests in chronic liver disease.
    Medical archives (Sarajevo, Bosnia and Herzegovina), 2012, Volume: 66, Issue:4

    Topics: Adult; Antithrombin III; Biomarkers; Blood Coagulation Tests; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; International Normalized Ratio; Liver Cirrhosis; Male; Middle Aged; Partial Thromboplastin Time; Protein C

2012
Serum fibrinogen alpha C-chain 5.9 kDa fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virus.
    Proteomics. Clinical applications, 2013, Volume: 7, Issue:5-6

    Topics: Adult; Aged; Biomarkers; Blood Specimen Collection; Early Diagnosis; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Reference Values; ROC Curve; Temperature; Time Factors

2013
[Electrophoretic determination of fibrinogen in hepatic cirrhosis and in other pathological conditions].
    Bollettino della Societa italiana di biologia sperimentale, 1953, Volume: 29, Issue:4

    Topics: Coagulants; Electrophoresis; Fibrinogen; Humans; Liver Cirrhosis

1953
[Fibrinogen content of the blood plasma in liver cirrhosis].
    Wiener medizinische Wochenschrift (1946), 1954, Sep-25, Volume: 104, Issue:39

    Topics: Fibrinogen; Humans; Liver Cirrhosis; Plasma

1954
[Possibility of differentiation of development of cirrhosis and neoplasms in ascitic fluid through determination of certain blood coagulation factors in ascitic fluid].
    Il Progresso medico, 1958, Jul-31, Volume: 14, Issue:14

    Topics: Ascites; Ascitic Fluid; Blood Coagulation Factors; Diagnosis, Differential; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Neoplasms; Prothrombin Time

1958
[Indices of blood coagulation processes (fibrinogen, prothrombin, factor V and factor VII) in the evaluation of functional conditions of the liver in Botkin's disease and cirrhosis].
    Transactions of the American Neurological Association, 1961, Volume: 69

    Topics: Blood Coagulation; Factor V; Factor VII; Fibrinogen; Hepatitis; Hepatitis A; Humans; Liver Cirrhosis; Prothrombin

1961
CIRCULATING FIBRINOLYTIC ACTIVATOR AND HEMORRHAGIC DIATHESIS.
    Annals of surgery, 1963, Volume: 158

    Topics: Aminocaproates; Aminocaproic Acid; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver Cirrhosis; Portacaval Shunt, Surgical; Postoperative Complications

1963
[CHANGES IN LIVER PROTEINS AND BLOOD PROTEINS IN EXPERIMENTAL LIVER CIRRHOSIS AND FOLLOWING DECORTIN AND ANABOLIC STEROID TREATMENT].
    Klinische Wochenschrift, 1963, Dec-01, Volume: 41

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Protein Electrophoresis; Ceruloplasmin; Clinical Enzyme Tests; Cytoplasm; D-Alanine Transaminase; Fibrinogen; Iron; Liver; Liver Cirrhosis; Liver Cirrhosis, Experimental; Mitochondria; Nandrolone; Oxidoreductases; Prednisone; Proteins; Prothrombin; Rats; Research; Sulfacetamide

1963
COAGULATION STUDIES IN LIVER DISEASE.
    Thrombosis et diathesis haemorrhagica, 1964, Apr-15, Volume: 11

    Topics: Blood Coagulation; Blood Coagulation Factors; Enzyme Inhibitors; Factor IX; Factor V; Factor VIII; Fibrinogen; Fibrinolysis; Hepatitis; Humans; Jaundice; Jaundice, Obstructive; Liver Cirrhosis; Liver Diseases; Prothrombin

1964
FIBRINOGEN CATABOLISM IN HUMANS.
    Clinical science, 1964, Volume: 26

    Topics: Blood Proteins; Blood Volume; Carcinoma; Fibrinogen; Geriatrics; Humans; Iodine Isotopes; Liver Cirrhosis; Liver Neoplasms; Physiology; Proteins; Tuberculosis; Tuberculosis, Pulmonary

1964
TURNOVER AND DISTRIBUTION OF 131-IODINE-LABELLED HUMAN FIBRINOGEN.
    Thrombosis et diathesis haemorrhagica, 1964, Jul-31, Volume: 11

    Topics: Arteriosclerosis; Blood Coagulation Tests; Coronary Disease; Diabetes Mellitus; Fibrinogen; Geriatrics; Humans; Intervertebral Disc Displacement; Iodine; Iodine Isotopes; Liver Cirrhosis; Lung Neoplasms; Metabolism; Radiometry; Thrombophlebitis; Thrombosis

1964
FIBRINOLYTIC BLEEDING AND ITS MANAGEMENT.
    Annals of the New York Academy of Sciences, 1964, Jul-09, Volume: 115

    Topics: Aminocaproates; Aminocaproic Acid; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver Cirrhosis; Niacin; Nicotinic Acids

1964
Abnormal hemorheological properties in patients with compensated and decompensated hepatic cirrhosis.
    Clinical hemorheology and microcirculation, 2003, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Blood Proteins; Blood Viscosity; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Liver Cirrhosis; Male; Middle Aged; N-Acetylneuraminic Acid; Patient Selection; Protein Binding; Reference Values

2003
The answer: angiotensin II. The question: what do inflammation, oxidant stress and fibrogenesis have in common?
    Journal of hepatology, 2004, Volume: 40, Issue:6

    Topics: Angiotensin II; Fibrinogen; Humans; Inflammation; Liver Cirrhosis; Oxidative Stress; Vasoconstriction

2004
[The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2005, Volume: 13, Issue:1

    Topics: Adult; Aged; Antithrombins; Blood Coagulation Factors; Female; Fibrinogen; Hemostasis; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Prothrombin Time; Severity of Illness Index

2005
Therapeutic effects and possible mechanisms of a snake venom preparation in the fibrotic rat liver.
    Digestive diseases and sciences, 2005, Volume: 50, Issue:4

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile; Carbon Tetrachloride; Dose-Response Relationship, Drug; Fibrinogen; Liver; Liver Circulation; Liver Cirrhosis; Male; Membrane Transport Proteins; Microcirculation; Organic Anion Transporters, Sodium-Dependent; Organic Anion Transporters, Sodium-Independent; Rats; Rats, Wistar; RNA, Messenger; Snake Venoms; Symporters; Taurocholic Acid; Thromboxane B2

2005
Vascular invasion and herniation by hepatocellular carcinoma in cirrhosis: A wolf in sheep's clothing?
    Archives of pathology & laboratory medicine, 2005, Volume: 129, Issue:5

    Topics: Actins; Adult; Biomarkers, Tumor; Carcinoma, Hepatocellular; Endothelium, Vascular; Factor XIIIa; Female; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Receptors, Complement 3b

2005
Importance of anticoagulant proteins in chronic liver diseases.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2005, Volume: 16, Issue:3

    Topics: Adult; Aged; Antithrombins; Bilirubin; Biomarkers; Blood Coagulation Factor Inhibitors; Blood Coagulation Tests; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Middle Aged; Protein C; Protein S; Serum Albumin; Severity of Illness Index

2005
Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy.
    BMC gastroenterology, 2005, Nov-15, Volume: 5

    Topics: Adult; Endoplasmic Reticulum; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Immunohistochemistry; Inclusion Bodies; Liver; Liver Cirrhosis; Metabolic Diseases; Microscopy, Electron; Necrosis

2005
Fibrin stabilizing factor (factor XIII) activity in liver cirrhosis.
    New Istanbul contribution to clinical science, 1967, Volume: 9, Issue:2

    Topics: Case-Control Studies; Factor XIII; Fibrinogen; Humans; Liver Cirrhosis; Severity of Illness Index

1967
Fibrinogen gamma375 arg-->trp mutation (fibrinogen aguadilla) causes hereditary hypofibrinogenemia, hepatic endoplasmic reticulum storage disease and cirrhosis.
    The American journal of surgical pathology, 2006, Volume: 30, Issue:7

    Topics: Adult; Afibrinogenemia; Amino Acid Sequence; Amino Acid Substitution; Arginine; Endoplasmic Reticulum; Family Health; Fibrinogen; Hepatocytes; Humans; Inclusion Bodies; Liver; Liver Cirrhosis; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Point Mutation; Tryptophan

2006
JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinase-independent phosphorylation.
    Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:6

    Topics: Actins; Alanine Transaminase; Animals; Anthracenes; Carbon Tetrachloride Poisoning; Extracellular Signal-Regulated MAP Kinases; Fibrinogen; Flavonoids; Humans; JNK Mitogen-Activated Protein Kinases; Liver; Liver Cirrhosis; Mice; Phosphorylation; Proto-Oncogene Proteins c-jun; Rats; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Transcription Factors; Transcription, Genetic

2006
Comparison of rheological parameters in patients with post hepatitic and alcoholic cirrhosis.
    Clinical hemorheology and microcirculation, 2007, Volume: 36, Issue:3

    Topics: Blood Viscosity; Chronic Disease; Erythrocyte Count; Erythrocyte Deformability; Fibrinogen; gamma-Globulins; Hemorheology; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Reference Values

2007
To aggregate or not to aggregate...
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:10

    Topics: Afibrinogenemia; Exons; Female; Fibrinogen; Heterozygote; Humans; Introns; Liver Cirrhosis; Mutation; Mutation, Missense; Platelet Aggregation; Protein Structure, Tertiary

2007
Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury.
    Journal of hepatology, 2007, Volume: 47, Issue:6

    Topics: Animals; Chemical and Drug Induced Liver Injury; Chronic Disease; Diet; Disease Models, Animal; Fibrinogen; Hepatocytes; Inflammation; Interferon-gamma; Liver Cirrhosis; Mice; Recombinant Proteins; Stem Cells

2007
[Ruptured cirrhotic nodulus treated with collagen patch].
    Orvosi hetilap, 2007, Dec-16, Volume: 148, Issue:50

    Topics: Abdomen, Acute; Aprotinin; Drug Combinations; Fibrinogen; Hemostasis, Surgical; Humans; Liver Cirrhosis; Male; Middle Aged; Rupture, Spontaneous; Thrombin; Treatment Outcome

2007
The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
    Journal of medicine, 1984, Volume: 15, Issue:2

    Topics: Adult; Afibrinogenemia; Aged; Blood Coagulation Tests; Carcinoma, Hepatocellular; Diagnosis, Differential; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Thrombin Time

1984
A clinical evaluation of serum alpha-1-antichymotrypsin levels in liver disease and cancers.
    Gastroenterologia Japonica, 1981, Volume: 16, Issue:6

    Topics: alpha 1-Antichymotrypsin; alpha-Fetoproteins; Blood Sedimentation; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Chymotrypsin; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Sialic Acids

1981
[Studies on the usefulness of the gamma globulin-fibrinogen index in differential diagnosis of liver diseases].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1983, Jul-01, Volume: 36, Issue:13

    Topics: Adolescent; Adult; Aged; Diagnosis, Differential; Female; Fibrinogen; gamma-Globulins; Hepatitis; Hepatitis B; Hepatitis, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged

1983
[Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Der Internist, 1984, Volume: 25, Issue:2

    Topics: Disseminated Intravascular Coagulation; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Glomerulonephritis; Hemostasis; Humans; Liver Cirrhosis; Postoperative Complications; Pulmonary Embolism; Thrombin; Thromboembolism; Thrombophlebitis

1984
Fibrinogen-bound sialic acid levels in the dysfibrinogenaemia of liver disease.
    Haemostasis, 1982, Volume: 11, Issue:4

    Topics: Afibrinogenemia; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Sialic Acids; Thrombin Time

1982
Study on coagulation profile of patients with cirrhosis of the liver undergoing elective fibreoptic injection sclerotherapy of oesophageal varices.
    Hepato-gastroenterology, 1984, Volume: 31, Issue:3

    Topics: Adult; Aged; Antithrombin III; Blood Coagulation Factors; Esophageal and Gastric Varices; Female; Fiber Optic Technology; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Sclerosing Solutions; Time Factors

1984
[Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis].
    Geburtshilfe und Frauenheilkunde, 1983, Volume: 43 Suppl 1

    Topics: Ascites; Ascitic Fluid; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Liver Cirrhosis; Ovarian Neoplasms

1983
Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients.
    Haemostasis, 1984, Volume: 14, Issue:2

    Topics: Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation; Blood Coagulation Tests; Female; Fibrinogen; Hepatitis, Chronic; Humans; Kallikreins; Liver Cirrhosis; Male; Middle Aged; Plasminogen; Platelet Count; Prekallikrein

1984
A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
    The Journal of laboratory and clinical medicine, 1981, Volume: 97, Issue:5

    Topics: Adsorption; Adult; Animals; Cattle; Fibrinogen; Fibrinolysis; Forearm; Humans; Liver Cirrhosis; Lysine; Plasminogen Activators; Serum Albumin; Serum Globulins; Thrombophlebitis

1981
Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shunt.
    Australian and New Zealand journal of medicine, 1981, Volume: 11, Issue:1

    Topics: Adult; Aged; Ascites; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Partial Thromboplastin Time; Peritoneovenous Shunt; Platelet Count; Postoperative Complications; Prospective Studies; Prothrombin Time; Thrombin Time; Vascular Surgical Procedures

1981
Effects of splenectomy on blood coagulation and fibrinolysis in patients with liver cirrhosis: possible role of the spleen in haemostasis.
    Thrombosis and haemostasis, 1980, Feb-29, Volume: 42, Issue:5

    Topics: Adult; Aged; Blood Coagulation; Female; Fibrinogen; Fibrinolysis; Fluorescent Antibody Technique; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Organ Size; Platelet Count; Spleen; Splenectomy; Time Factors

1980
Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
    The Journal of laboratory and clinical medicine, 1982, Volume: 99, Issue:2

    Topics: Blood Platelets; Fibrinogen; Hemostasis; Heparin; Humans; Kinetics; Liver; Liver Cirrhosis; Plasminogen; Platelet Aggregation; Platelet Count; Protein Biosynthesis; Prothrombin Time

1982
Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Possible implications for enhanced fibrinolysis.
    The American journal of medicine, 1982, Volume: 73, Issue:2

    Topics: Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Female; Fibrinogen; Fibrinolysis; Glycoproteins; Humans; Liver Cirrhosis; Male; Middle Aged; Plasminogen; Proteins; Serum Albumin

1982
Antithrombin III transfusion in patients with hepatic cirrhosis.
    British journal of haematology, 1982, Volume: 52, Issue:1

    Topics: Adult; Aged; Antithrombin III; Antithrombin III Deficiency; Blood Coagulation; Female; Fibrinogen; Half-Life; Humans; Liver Cirrhosis; Male; Middle Aged

1982
Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhosis.
    British journal of haematology, 1982, Volume: 52, Issue:3

    Topics: Female; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Liver Cirrhosis; Male; Molecular Weight

1982
[Changes in fibrin formation in liver cirrhosis].
    Sangre, 1982, Volume: 27, Issue:4-B

    Topics: Adult; Blood Coagulation Disorders; Fetal Blood; Fibrin; Fibrinogen; Humans; Infant, Newborn; Liver; Liver Cirrhosis

1982
Increased plasma antithrombin III level in hyperlipidemic subjects.
    Clinica chimica acta; international journal of clinical chemistry, 1981, Mar-05, Volume: 110, Issue:2-3

    Topics: Adult; Aged; Antithrombin III; Butyrylcholinesterase; Cholesterol; Female; Fibrinogen; Humans; Hyperlipidemias; Liver Cirrhosis; Male; Middle Aged; Obesity; Triglycerides

1981
[Electrophoretic changes in fibrinogen in liver cirrhosis].
    Gaceta medica de Mexico, 1981, Volume: 117, Issue:1

    Topics: Blood Protein Electrophoresis; Fibrinogen; Hepatitis, Viral, Human; Humans; Immunoelectrophoresis; Liver Cirrhosis

1981
Importance of the liver in the regulation of platelet activity: effect of its functional exclusion (Eck fistula).
    Haemostasis, 1980, Volume: 9, Issue:1

    Topics: Adenosine Diphosphate; Animals; Binding Sites; Blood Coagulation; Blood Platelets; Fibrinogen; Humans; Liver; Liver Cirrhosis; Platelet Aggregation; Platelet Count; Portacaval Shunt, Surgical; Rats

1980
Structure of fibrin and fibrinmonomer in renal and hepatic failure.
    Klinische Wochenschrift, 1980, May-16, Volume: 58, Issue:10

    Topics: Factor XIII; Fibrin; Fibrinogen; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Protein Conformation

1980
Hemostatic function in cancer patients.
    Cancer, 1980, Aug-15, Volume: 46, Issue:4

    Topics: Adolescent; Adult; Aged; Antithrombin III; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Neoplasm Metastasis; Neoplasms

1980
Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation.
    Transfusion, 1994, Volume: 34, Issue:6

    Topics: Adult; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Erythrocyte Transfusion; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Plasma; Platelet Transfusion

1994
Acute phase response after liver transplantation for fulminant hepatic failure and cirrhosis.
    Transplant international : official journal of the European Society for Organ Transplantation, 1995, Volume: 8, Issue:5

    Topics: Acute-Phase Reaction; Adult; alpha 1-Antitrypsin; C-Reactive Protein; Female; Fibrinogen; Hepatic Encephalopathy; Humans; Interleukin-6; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged

1995
Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays.
    Thrombosis research, 1995, May-15, Volume: 78, Issue:4

    Topics: Child; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis

1995
[Fibrinolysis in chronic liver diseases studied by in vitro blood coagulation tests].
    Orvosi hetilap, 1994, Dec-18, Volume: 135, Issue:51

    Topics: Adult; Aged; Antifibrinolytic Agents; Blood Coagulation Tests; Cholestasis; Chronic Disease; Female; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Male; Middle Aged; Prognosis; Tissue Plasminogen Activator

1994
Relationship between lipoprotein(a) levels in serum and some indices of protein synthesis in liver cirrhosis.
    Clinica chimica acta; international journal of clinical chemistry, 1994, Jan-31, Volume: 224, Issue:2

    Topics: Apolipoprotein B-100; Apolipoproteins B; Cholesterol; Female; Fibrinogen; Humans; Lipoprotein(a); Liver; Liver Cirrhosis; Male; Middle Aged; Protein Biosynthesis; Prothrombin Time; Serum Albumin; Triglycerides

1994
[Disorders of coagulation/fibrinolysis and bleeding tendency].
    Nihon rinsho. Japanese journal of clinical medicine, 1994, Volume: 52, Issue:1

    Topics: Antithrombin III; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver Cirrhosis; Plasminogen; Protein C

1994
A new method of purification and sensitive bioassay of platelet-activating factor (PAF) in human whole blood.
    Life sciences, 1994, Volume: 54, Issue:6

    Topics: Animals; Biological Assay; Epinephrine; Fibrinogen; Humans; Infections; Liver Cirrhosis; Platelet Activating Factor; Platelet Aggregation; Rabbits; Radioimmunoassay; Sensitivity and Specificity

1994
Clinical studies on plasma protein C. Correlation with serum cholinesterase.
    Nouvelle revue francaise d'hematologie, 1993, Volume: 35, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Cholestasis; Cholesterol; Cholinesterases; Critical Illness; Female; Fibrinogen; Humans; Hypertriglyceridemia; Liver Cirrhosis; Male; Middle Aged; Nephrotic Syndrome; Obesity; Protein C; Triglycerides

1993
Disordered hemostasis in extrahepatic portal hypertension.
    Hepatology (Baltimore, Md.), 1993, Volume: 18, Issue:4

    Topics: Adult; Blood Coagulation; Blood Coagulation Factors; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Portal Vein; Thrombosis

1993
Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver.
    Hepatology (Baltimore, Md.), 1996, Volume: 24, Issue:1

    Topics: Adult; Aged; Aminopyrine; Blood Volume; Deuterium; Fibrinogen; Galactose; Gas Chromatography-Mass Spectrometry; Hepatitis B; Hepatitis C; Humans; Kinetics; Liver Cirrhosis; Male; Middle Aged; Phenylalanine; Radioisotope Dilution Technique; Serum Albumin

1996
Influence of plasma composition on erythrocyte filtrability in alcoholic liver disease.
    Alcohol and alcoholism (Oxford, Oxfordshire). Supplement, 1994, Volume: 29, Issue:1

    Topics: Blood Viscosity; Erythrocyte Deformability; Fibrinogen; Glycerides; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Alcoholic

1994
Lipoprotein (a) serum levels in patients with hepatocarcinoma.
    Clinica chimica acta; international journal of clinical chemistry, 1997, Jun-27, Volume: 262, Issue:1-2

    Topics: Aged; Apolipoprotein B-100; Apolipoproteins B; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Lipoprotein(a); Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Serum Albumin

1997
Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma.
    Italian journal of gastroenterology and hepatology, 1997, Volume: 29, Issue:5

    Topics: Carcinoma, Hepatocellular; Copper; Female; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Zinc

1997
[Alterations of hemostasis in liver cirrhosis of the dog].
    DTW. Deutsche tierarztliche Wochenschrift, 1998, Volume: 105, Issue:2

    Topics: Animals; Blood Coagulation Factors; Dog Diseases; Dogs; Fibrin; Fibrinogen; Hemostasis; Humans; Liver Cirrhosis; Reference Values

1998
Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    The American journal of gastroenterology, 1999, Volume: 94, Issue:10

    Topics: Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Protein Precursors; Prothrombin; Prothrombin Time; Thrombelastography

1999
Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:11

    Topics: Ascitic Fluid; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Male; Middle Aged; Plasminogen

2000
Genetic and immunological characterization of fibrinogen inclusion bodies in patients with hepatic fibrinogen storage and liver disease.
    Annals of the New York Academy of Sciences, 2001, Volume: 936

    Topics: Fibrinogen; Genetic Predisposition to Disease; Humans; Immunohistochemistry; Liver; Liver Cirrhosis; Liver Diseases

2001
Platelet aggregation in portal cirrhosis.
    Archives of internal medicine, 1976, Volume: 136, Issue:3

    Topics: Adenosine Diphosphate; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Platelet Aggregation; Serum Globulins; Thrombin

1976
Immunologic measurement of antithrombin III-heparin cofactor and alpha2 macroglobulin in disseminated intravascular coagulation and hepatic failure coagulopathy.
    Thrombosis research, 1975, Volume: 6, Issue:1

    Topics: Alpha-Globulins; Antithrombin III; Antithrombins; Aspirin; Blood Platelets; Chemical and Drug Induced Liver Injury; Disseminated Intravascular Coagulation; Female; Fetal Proteins; Fibrinogen; Humans; Immunoelectrophoresis; Liver Cirrhosis; Macroglobulins; Male

1975
Coagulative and fibrinolytic properties of ascitic fluid associated with ovarian tumors.
    Cancer, 1975, Volume: 35, Issue:5

    Topics: Alpha-Globulins; Antithrombins; Ascitic Fluid; Coagulants; Factor V; Factor VIII; Female; Fibrinogen; Fibrinolytic Agents; Humans; Liver Cirrhosis; Ovarian Neoplasms; Plasminogen; Trypsin Inhibitors; Urokinase-Type Plasminogen Activator

1975
Heparin cofactor activity measured with an amidolytic method.
    Thrombosis research, 1975, Volume: 6, Issue:4

    Topics: Acute Disease; Alpha-Globulins; Antithrombin III; Antithrombins; Biological Assay; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Heparin; Hexadimethrine Bromide; Humans; Liver Cirrhosis; Methods; Myocardial Infarction; Spectrophotometry; Thrombin

1975
[Localization of HBsAg, immunoglobulins, fibrin and C3 in the liver by direct immunoflourescence].
    Pathologie-biologie, 1976, Volume: 24, Issue:5

    Topics: Biopsy; Complement C3; Complement System Proteins; Cytoplasm; Epitopes; Fatty Liver; Fibrin; Fibrinogen; Fluorescent Antibody Technique; Hepatitis; Hepatitis B Antigens; Humans; Immunoglobulins; Liver; Liver Cirrhosis; Liver Diseases; Renal Dialysis

1976
Schistosoma japonicum: anti-DNA responses, serum cryogelatification, and cryoprecipitation phenomena in infected rabbits.
    Experimental parasitology, 1977, Volume: 42, Issue:2

    Topics: alpha-Macroglobulins; Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Chemical Precipitation; Cold Temperature; Fibrinogen; Gels; Immunoglobulin G; Immunoglobulin M; Kidney Glomerulus; Liver Cirrhosis; Rabbits; Schistosoma; Schistosomiasis

1977
[First clinical experiences with the small molecular synthetic thrombin inhibitor 4-amidinophenylpyruvic acid (APPA)].
    Folia haematologica (Leipzig, Germany : 1928), 1977, Volume: 104, Issue:6

    Topics: Adult; Aged; Amidines; Angiomatosis; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Male; Middle Aged; Phenylpyruvic Acids; Polycythemia; Thrombin

1977
Regulation of the thrombin time in cirrhosis.
    Thrombosis research, 1976, Volume: 9, Issue:4

    Topics: Antithrombin III; Antithrombins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Humans; Liver Cirrhosis; Plasminogen; Prothrombin Time; Thrombin; Thromboplastin; Thrombosis; Time Factors

1976
Abnormal fibrin polymerization in liver disease.
    British journal of haematology, 1976, Volume: 34, Issue:3

    Topics: Batroxobin; Blood Coagulation Tests; Carcinoma, Hepatocellular; Cholestasis; Chronic Disease; Fibrin; Fibrinogen; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Polymers; Thrombin; Time Factors

1976
Coagulation abnormalities in liver disease.
    Seminars in thrombosis and hemostasis, 1977,Summer, Volume: 4, Issue:1

    Topics: Acute Disease; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; Carcinoma, Hepatocellular; Chronic Disease; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XIII; Fibrinogen; Hepatitis; Humans; Jaundice, Chronic Idiopathic; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Neoplasm Metastasis; Prothrombin; Vitamin K

1977
Reptilase time in cirrhosis and hepatocellular carcinoma.
    British medical journal, 1977, Oct-01, Volume: 2, Issue:6091

    Topics: Batroxobin; Carcinoma, Hepatocellular; Fibrinogen; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Peptide Hydrolases

1977
Investigations on intravascular coagulation in liver disease: souble fibrin monomer complexes in liver cirrhosis.
    Haemostasis, 1979, Volume: 8, Issue:1

    Topics: Bacteriological Techniques; Blood Coagulation; Blood Coagulation Tests; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Injections, Subcutaneous; Liver Cirrhosis; Liver Diseases; Solubility; Staphylococcus

1979
Relationship between endotoxaemia and protein concentration of ascites in cirrhotic patients.
    Gut, 1979, Volume: 20, Issue:3

    Topics: Adult; Aged; Albumins; Ascitic Fluid; Blood Proteins; Endotoxins; Female; Fibrinogen; Globulins; Humans; Limulus Test; Liver Cirrhosis; Male; Middle Aged; Proteins; Specific Gravity

1979
Fibrinopeptide A in human plasma--evaluation of a new radioimmunoassay technique on microliter--plates.
    Thrombosis research, 1979, Volume: 15, Issue:3-4

    Topics: Animals; Dialysis; Fibrinogen; Fibrinopeptide A; Humans; Immune Sera; Liver Cirrhosis; Rabbits; Radioimmunoassay; Time Factors

1979
A test method for the absence of thrombogenicity in factor IX complex.
    Developments in biological standardization, 1979, Volume: 44

    Topics: Adult; Aged; Blood Coagulation; Factor IX; Fibrinogen; Hemophilia A; Hemostasis; Heparin; Humans; Liver Cirrhosis; Male; Middle Aged; Quality Control

1979
[Biological significance of fibrinopeptide A elevation in the blood].
    Schweizerische medizinische Wochenschrift, 1977, Dec-03, Volume: 107, Issue:48

    Topics: Breast Neoplasms; Bronchial Neoplasms; Fatty Liver; Female; Fibrinogen; Fibrinopeptide A; Half-Life; Humans; Liver Cirrhosis; Lymphoma, Non-Hodgkin; Pleural Effusion

1977
Association of abnormal fibrin polymerisation with severe liver disease.
    Gut, 1977, Volume: 18, Issue:11

    Topics: Aspartate Aminotransferases; Bilirubin; Blood Coagulation Disorders; Chronic Disease; Factor VII; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Serum Albumin; Serum Globulins

1977
Fibrinogen, fibrin degradation products and fibrinolysis in bilharzial (schistosomal) hepatic fibrosis.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 1977, Volume: 71, Issue:4

    Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Liver Cirrhosis; Schistosomiasis

1977
[Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)].
    Zeitschrift fur Gastroenterologie, 1978, Volume: 16, Issue:9

    Topics: Blood Coagulation Disorders; Blood Platelets; Cell Count; Electrophoresis, Polyacrylamide Gel; Factor XIII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Liver Cirrhosis; Sodium Dodecyl Sulfate

1978
Quantitative abnormality of an Aalpha chain molecular weight form in the fibrinogen of cirrhotic patients.
    British journal of haematology, 1978, Volume: 40, Issue:4

    Topics: Blood Coagulation Tests; Densitometry; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Male; Molecular Weight; Thrombin

1978
Thrombin time prolongation in cirrhosis in relation to enhanced fibrinogen degradation.
    Thrombosis research, 1977, Volume: 10, Issue:1

    Topics: Electrophoresis, Polyacrylamide Gel; Fibrinogen; Humans; Liver Cirrhosis; Molecular Weight; Prothrombin Time

1977
[Value of thermal fractionation of lactate dehydrogenase and the protein composition of the blood in the differential diagnosis of the phases of acute pancreatitis].
    Vestnik khirurgii imeni I. I. Grekova, 1977, Volume: 118, Issue:1

    Topics: Acute Disease; Blood Proteins; C-Reactive Protein; Clinical Enzyme Tests; Diagnosis, Differential; Fibrinogen; Hepatitis, Viral, Human; Humans; L-Lactate Dehydrogenase; Liver Cirrhosis; Pancreatitis

1977
Impaired fibrin formation in advanced cirrhosis.
    Haemostasis, 1977, Volume: 6, Issue:2

    Topics: Adult; Aged; Blood Coagulation Tests; Fibrin; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Middle Aged; Polymers; Thrombin; Time Factors

1977
Dysfibrinogenemia associated with liver disease.
    The Journal of clinical investigation, 1977, Volume: 60, Issue:1

    Topics: Alcoholism; Batroxobin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Chemical and Drug Induced Liver Injury; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Thrombin

1977
[Metabolism of fibrinogen in the cirrhotic patient. Dynamic study by isotope method].
    La Nouvelle presse medicale, 1976, Jun-19, Volume: 5, Issue:25

    Topics: Biological Clocks; Disseminated Intravascular Coagulation; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Liver Cirrhosis

1976
Change of the molecular mass of fibrinogen in circulating blood, as an index of the hypercoagulable states.
    Thrombosis research, 1976, Volume: 8, Issue:2 suppl

    Topics: Adult; Aged; Antigens; Blood Protein Disorders; Cold Temperature; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Leukemia; Liver Cirrhosis; Male; Thrombosis

1976
[Hepatic cirrhosis and clearance of fibrinolysis activators].
    Revista clinica espanola, 1976, Jul-31, Volume: 142, Issue:2

    Topics: Fibrinogen; Fibrinolysis; Humans; Liver; Liver Cirrhosis; Nicotinic Acids; Plasminogen Activators; Stimulation, Chemical

1976
[Changes of blood-flow properties in patients with chronic liver disease (author's transl)].
    Clinica chimica acta; international journal of clinical chemistry, 1975, Jun-02, Volume: 61, Issue:2

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Viscosity; Chronic Disease; Cortisone; Esophageal and Gastric Varices; Fibrinogen; Hepatitis; Humans; Hypertension, Portal; Immunoglobulin G; Immunosuppression Therapy; Liver Cirrhosis; Liver Diseases; Middle Aged

1975
[Acanthocytosis of red blood cells. A case during hepatic cirrhosis with hemolysis and defibrination].
    La Nouvelle presse medicale, 1975, Jan-11, Volume: 04, Issue:2

    Topics: Anemia, Hemolytic; Blood Coagulation Disorders; Erythrocytes, Abnormal; Fibrinogen; Humans; Liver Cirrhosis; Male; Microscopy, Electron; Middle Aged; Polymers; Thrombin

1975
Fibrinogen survival in cirrhosis: improvement by "low dose" heparin.
    Annals of internal medicine, 1975, Volume: 83, Issue:1

    Topics: Disseminated Intravascular Coagulation; Fibrinogen; Half-Life; Heparin; Humans; Iodine Radioisotopes; Liver Cirrhosis; Time Factors

1975
In vitro pleural fluid clottability and fibrinogen content.
    Chest, 1975, Volume: 68, Issue:2

    Topics: Adult; Arthritis, Rheumatoid; Blood Coagulation Tests; Blood Proteins; Female; Fibrinogen; Fibrinolysis; Heart Failure; Hodgkin Disease; Humans; In Vitro Techniques; Liver Cirrhosis; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pneumonia; Tuberculosis, Pulmonary

1975
Proceedings: Abnormal fibrin monomer polymerization in liver disease.
    Gut, 1975, Volume: 16, Issue:10

    Topics: Fibrin; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Liver Diseases

1975
The extent of diffuse intravascular coagulation and fibrinolysis in patients with liver cirrhosis.
    European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies, 1992, Volume: 30, Issue:5

    Topics: Adult; Aged; Antithrombin III; Blood Coagulation Factors; Cholinesterases; Female; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Male; Middle Aged; Tissue Plasminogen Activator

1992
Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.
    The American surgeon, 1991, Volume: 57, Issue:4

    Topics: Adult; Aged; alpha-Macroglobulins; Antifibrinolytic Agents; Antithrombin III; Cefazolin; Esophageal and Gastric Varices; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibronectins; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Peptide Hydrolases; Plasminogen Inactivators; Protein C; Sclerotherapy; Sodium Tetradecyl Sulfate; Thrombin; Tissue Plasminogen Activator

1991
Sandwich enzyme immunoassay for serum integrins using monoclonal antibodies.
    Clinica chimica acta; international journal of clinical chemistry, 1991, Oct-31, Volume: 202, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Glycoproteins; Hepatitis; Humans; Immunoblotting; Immunoenzyme Techniques; Integrins; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasms; Platelet Membrane Glycoproteins; Receptors, Immunologic; Receptors, Vitronectin; Reference Values; Vitronectin

1991
Correlations between plasma levels of fibrin(ogen) derivatives as quantified by different assays based on monoclonal antibodies.
    Thrombosis research, 1991, Feb-15, Volume: 61, Issue:4

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Immunoenzyme Techniques; Liver Cirrhosis; Male; Middle Aged; Plasma; Thrombosis

1991
Hemorrheological changes in chronic hepatitis and liver cirrhosis and their relations to the syndromes differentiated by traditional Chinese medicine.
    Chinese medical journal, 1990, Volume: 103, Issue:11

    Topics: Adult; Blood Viscosity; Chronic Disease; Female; Fibrinogen; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Male; Medicine, Chinese Traditional; Middle Aged; Regional Blood Flow; Tongue

1990
Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
    The Italian journal of gastroenterology, 1990, Volume: 22, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Prothrombin

1990
The use of laser-nephelometry in evaluating fibrinogenaemia in patients with hepatocarcinoma and cirrhosis.
    Folia haematologica (Leipzig, Germany : 1928), 1985, Volume: 112, Issue:6

    Topics: Carcinoma, Hepatocellular; Fibrinogen; Humans; Kinetics; Lasers; Liver Cirrhosis; Liver Neoplasms; Nephelometry and Turbidimetry

1985
Fibrinopeptide A and B beta 15-42 in liver cirrhosis.
    Haemostasis, 1988, Volume: 18, Issue:2

    Topics: Adult; alpha-2-Antiplasmin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Peptide Fragments

1988
Use of microcrystalline collagen powder and fibrinogen tissue adhesive for hemostasis and prevention of rebleeding in patients with hepatocellular carcinoma associated with cirrhosis of the liver.
    Surgery, gynecology & obstetrics, 1989, Volume: 168, Issue:5

    Topics: Aprotinin; Carcinoma, Hepatocellular; Collagen; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Powders; Thrombin; Tissue Adhesives

1989
[Fibrin glue injection--a hemostatic technic after laparoscopic liver biopsy].
    Deutsche medizinische Wochenschrift (1946), 1989, Aug-04, Volume: 114, Issue:31-32

    Topics: Adult; Aged; Aprotinin; Biopsy, Needle; Drug Combinations; Factor XIII; Female; Fibrin; Fibrin Tissue Adhesive; Fibrinogen; Hemostatic Techniques; Humans; Laparoscopy; Liver; Liver Cirrhosis; Male; Middle Aged; Thrombin; Tissue Adhesives

1989
Endoplasmic storage disease of liver: characterization of intracytoplasmic hyaline inclusions.
    Histopathology, 1989, Volume: 15, Issue:5

    Topics: Adult; Carcinoma, Hepatocellular; Complement C3; Complement C4; Endoplasmic Reticulum; Fibrinogen; Hepatitis B; Humans; Hyalin; Inclusion Bodies; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male

1989
[Anti-fibrinogen antibodies in chronic diseases of the liver].
    Polskie Archiwum Medycyny Wewnetrznej, 1989, Volume: 81, Issue:1

    Topics: Adult; Autoantibodies; Chronic Disease; Fatty Liver; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Male; Middle Aged

1989
Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease.
    Blood, 1986, Volume: 67, Issue:5

    Topics: Agglutination; Alcoholism; Antibodies; Electrophoresis, Polyacrylamide Gel; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Hemosiderosis; Hepatitis; Humans; Immunosorbent Techniques; Liver Cirrhosis; Liver Diseases; Molecular Weight; Platelet Count; Polymers; Thrombin Time

1986
Diagnostic and prognostic value of serum copper and plasma fibrinogen in hepatic carcinoma.
    Cancer, 1985, Feb-15, Volume: 55, Issue:4

    Topics: Adenoma, Bile Duct; Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Copper; Diagnosis, Differential; Female; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged

1985
A DIC-like picture on plasma and ascitic fluid of cirrhotic patients.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1988, Volume: 188, Issue:5

    Topics: Aged; Ascites; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Humans; Liver Cirrhosis; Male; Middle Aged; Partial Thromboplastin Time; Plasminogen; Prothrombin Time; Reference Values; Tissue Plasminogen Activator

1988
[Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?].
    Minerva medica, 1988, Volume: 79, Issue:3

    Topics: Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time

1988
[Serum levels of fibrinogen degradation products in patients with hepatic cirrhosis].
    Recenti progressi in medicina, 1987, Volume: 78, Issue:10

    Topics: Adult; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged

1987
Analysis of fibrinogen degradation product in severe liver disorders by immunoblotting.
    The Tohoku journal of experimental medicine, 1987, Volume: 153, Issue:3

    Topics: Collodion; Disseminated Intravascular Coagulation; Electrophoresis, Polyacrylamide Gel; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Molecular Weight

1987
Study of the formation of fibrin clot in cirrhotic patients. An approach to study of acquired dysfibrinogenemia.
    Thrombosis research, 1987, Jun-01, Volume: 46, Issue:5

    Topics: Afibrinogenemia; Blood Coagulation; Blood Coagulation Tests; Cross Reactions; Electrophoresis, Polyacrylamide Gel; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Molecular Weight; Protein Conformation

1987
Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Thrombosis and haemostasis, 1987, Aug-04, Volume: 58, Issue:2

    Topics: Collagen Diseases; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Liver Cirrhosis; Myocardial Infarction; Neoplasms; Thromboembolism

1987
Turnover study of prothrombin, antithrombin III and fibrinogen in patients with liver cirrhosis.
    Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society, 1986, Volume: 49, Issue:6

    Topics: Adult; Aged; Antithrombin III; Blood Coagulation Tests; Female; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Prothrombin

1986
The effect of carbon tetrachloride-induced cirrhosis of the liver on fibrinogen-bound sialic acid and sialyltransferase activity in the rat.
    Medical laboratory sciences, 1986, Volume: 43, Issue:1

    Topics: Animals; Carbon Tetrachloride; Fibrinogen; Liver Cirrhosis; Male; N-Acetylneuraminic Acid; Protein Binding; Rats; Rats, Inbred Strains; Sialic Acids; Sialyltransferases; Transferases

1986
Antibodies and intravascular clotting in liver cirrhosis.
    Lancet (London, England), 1972, May-27, Volume: 1, Issue:7761

    Topics: Animals; Antibodies; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Liver Cirrhosis

1972
F.D.P.
    Lancet (London, England), 1972, Dec-16, Volume: 2, Issue:7790

    Topics: Ascitic Fluid; Female; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Ovarian Neoplasms

1972
[Fibrinolytic potential of the blood in liver damage].
    Folia haematologica (Leipzig, Germany : 1928), 1974, Volume: 101, Issue:1

    Topics: Antithrombins; Blood Coagulation Tests; Caseins; Factor V; Factor VIII; Fibrinogen; Fibrinolysis; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Mushroom Poisoning; Plasminogen; Prothrombin Time; Thromboplastin

1974
[Disseminated intravascular coagulation in blastic leukemia and certain other disorders].
    Folia haematologica (Leipzig, Germany : 1928), 1974, Volume: 101, Issue:2

    Topics: Acute Disease; Antithrombins; Blood Cell Count; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Liver Cirrhosis; Lymphatic Diseases; Platelet Adhesiveness; Prothrombin Time; Retinal Detachment; Thrombin; Thrombophlebitis

1974
The fibrinolytic enzyme system in acute and chronic liver injury.
    Acta haematologica, 1974, Volume: 52, Issue:5

    Topics: Acute Disease; Adult; Aged; Alcoholism; alpha 1-Antitrypsin; Alpha-Globulins; Chronic Disease; Fatty Liver; Female; Fibrin; Fibrinogen; Fibrinolysis; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Macroglobulins; Male; Middle Aged; Plasminogen

1974
Investigations on plasma viscosity in patients with cirrhosis of the liver.
    Acta hepato-gastroenterologica, 1974, Volume: 21, Issue:2

    Topics: Blood Proteins; Blood Viscosity; Cholinesterases; Fibrinogen; gamma-Globulins; Humans; Liver Cirrhosis; Serum Albumin

1974
Fibrinogen-transmitted hepatitis; a controlled study.
    JAMA, 1966, Feb-07, Volume: 195, Issue:6

    Topics: Abruptio Placentae; Afibrinogenemia; Aortic Aneurysm; Aspartate Aminotransferases; Embolism, Amniotic Fluid; Female; Fetal Death; Fibrinogen; gamma-Globulins; Hemorrhage; Hepatitis B; Humans; Liver Cirrhosis; Placenta Previa; Pregnancy; Thoracic Surgery; Thorax; Uterine Rupture

1966
Circulating heparin-like anticoagulant following portacaval anastomosis.
    Lancet (London, England), 1970, Sep-26, Volume: 2, Issue:7674

    Topics: Anticoagulants; Aprotinin; Blood Coagulation Tests; Fibrinogen; Heparin; Humans; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical; Protamines

1970
Disseminated intravascular coagulation during a fatal Mycoplasma pneumoniae infection.
    Acta haematologica, 1974, Volume: 52, Issue:2

    Topics: Adult; Antibodies, Bacterial; Complement Fixation Tests; Complement System Proteins; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Hypotension; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Liver Cirrhosis; Male; Mycoplasma; Mycoplasma Infections; Purpura; Respiratory Insufficiency; Shock, Hemorrhagic; Thrombocytopenia

1974
Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis.
    The Journal of laboratory and clinical medicine, 1967, Volume: 70, Issue:6

    Topics: Acrylates; Agar; Aminocaproates; Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Electrophoresis; Extracorporeal Circulation; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Gels; Humans; Immune Sera; Immunoelectrophoresis; Liver Cirrhosis; Male; Molecular Weight; Nicotinic Acids; Plasma; Prostatic Neoplasms; Rabbits

1967
Plasmatic and platelet anti-plasmins and anti-activators. 3. Results in normal people, in patients and in those with venous thrombosis.
    Thrombosis et diathesis haemorrhagica, 1969, Feb-28, Volume: 21, Issue:1

    Topics: Antifibrinolytic Agents; Blood Platelets; Blood Protein Electrophoresis; Enzymes; Fibrinogen; Fibrinolysin; Freezing; Humans; Liver Cirrhosis; Temperature; Thrombosis

1969
Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    The Journal of laboratory and clinical medicine, 1970, Volume: 75, Issue:1

    Topics: Animals; Arthritis, Rheumatoid; Blood Coagulation Tests; Cats; Cattle; Chromatography, Gel; Electrophoresis; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Liver Cirrhosis; Methods; Prothrombin Time; Rabbits; Staphylococcus; Streptokinase; Thrombin; Thrombosis; Time Factors

1970
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
    The New England journal of medicine, 1970, Sep-24, Volume: 283, Issue:13

    Topics: Adult; Agglutination Tests; Arthritis, Rheumatoid; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral; Erythrocytes; False Negative Reactions; False Positive Reactions; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemagglutination Inhibition Tests; Hodgkin Disease; Humans; Immunoassay; Immunodiffusion; Kidney Diseases; Liver Cirrhosis; Lymphoma, Non-Hodgkin; Male; Methods; Middle Aged; Myocardial Infarction; Neoplasms; Plasminogen; Staphylococcus

1970
The clinical significance of fibrinogen-fibrin-related antigen in serum.
    Scandinavian journal of haematology. Supplementum, 1971, Volume: 13

    Topics: Abruptio Placentae; Antigens; Blood Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Liver Cirrhosis; Neoplasms; Pregnancy

1971
Fibrinolytic activity in hepatic cirrhosis.
    Digestion, 1972, Volume: 6, Issue:3

    Topics: Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Immunodiffusion; Immunoelectrophoresis; Liver Cirrhosis; Plasminogen

1972
[Coagulation disorders after reinjection of concentrated ascitic fluid. Preliminary study].
    Medecine & chirurgie digestives, 1973, Volume: 2, Issue:5

    Topics: Aminocaproates; Ascitic Fluid; Blood Coagulation Disorders; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysin; Hemorrhage; Humans; Infusions, Parenteral; Liver Cirrhosis; Plasminogen

1973
[Changes in the carbohydrate composition of fibrinogen in cases of acquired dysfibrinogenemia].
    Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles, 1970, Nov-16, Volume: 271, Issue:20

    Topics: Blood Coagulation Disorders; Blood Protein Disorders; Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry; Fibrinogen; Hexosamines; Hexoses; Humans; Jaundice; Liver Cirrhosis; Liver Neoplasms; Neuraminic Acids

1970
Plasma fibrinogen in health and disease. Its application in the differential diagnosis of an enlarged and irregular liver.
    The American journal of gastroenterology, 1972, Volume: 57, Issue:1

    Topics: Adult; Aged; Alcoholism; Carcinoma, Hepatocellular; Fatty Liver; Fibrinogen; Hepatomegaly; Humans; Intestinal Neoplasms; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis

1972
[Acquired dysfibrinogenemia and hepatic disorders. Apropos of 30 cases].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1973, Jan-14, Volume: 49, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Alcoholism; Blood Coagulation Disorders; Blood Coagulation Tests; Female; Fibrinogen; Giant Cell Arteritis; Hepatitis; Hepatitis A; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Prognosis

1973
Fibrinogen in liver disease.
    Archives of surgery (Chicago, Ill. : 1960), 1974, Volume: 109, Issue:6

    Topics: Acetaminophen; Chemical and Drug Induced Liver Injury; Cholangitis; Cholestasis; Contusions; Endotoxins; Fibrinogen; Humans; Iodine Radioisotopes; Liver; Liver Cirrhosis; Liver Diseases; Pseudomonas Infections; Sepsis; Toxemia

1974
Regulation of fibrinogen synthesis in portal hypertension.
    Thrombosis et diathesis haemorrhagica, 1974, Dec-31, Volume: 32, Issue:2-3

    Topics: Animals; Blood Coagulation Factors; Blood Volume; Body Weight; Carbon Radioisotopes; Female; Fibrinogen; Guinea Pigs; Hypertension, Portal; Leucine; Ligation; Liver; Liver Cirrhosis; Male; Organ Size; Portacaval Shunt, Surgical; Portal Vein

1974
[Coagulation and fibrinolytic systems of the blood in patients with cirrhosis and primary cancer of the liver].
    Klinicheskaia meditsina, 1974, Volume: 52, Issue:2

    Topics: Blood Coagulation; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Liver Neoplasms

1974
Abnormalities of platelet aggregation in patients with alcoholic cirrhosis.
    Annals of the New York Academy of Sciences, 1972, Oct-27, Volume: 201

    Topics: Alcoholism; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Platelet Adhesiveness

1972
Coagulation factors as indicators of protein synthesis in chronic liver disease.
    Scandinavian journal of gastroenterology. Supplement, 1973, Volume: 19

    Topics: Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Chronic Disease; Female; Fibrinogen; Hepatitis; Humans; Indicators and Reagents; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Methods; Serum Albumin

1973
Heparin therapy in the case of acute liver cirrhosis.
    Scandinavian journal of gastroenterology. Supplement, 1973, Volume: 19

    Topics: Acute Disease; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Disseminated Intravascular Coagulation; Factor IX; Factor V; Factor VII; Factor X; Factor XIII; Female; Fibrinogen; Heparin; Humans; Liver Cirrhosis; Male; Methods; Prothrombin; Serum Globulins; Solubility; Vitamin K 1

1973
The diagnostic value of coagulation studies in chronic liver disease.
    Scandinavian journal of gastroenterology. Supplement, 1973, Volume: 19

    Topics: Blood Coagulation Tests; Chronic Disease; Factor V; Fibrinogen; Hepatitis; Humans; Indicators and Reagents; Liver Cirrhosis; Liver Diseases; Methods; Prothrombin Time

1973
[On the diagnosis of imminent bleeding from esophageal varices (author's transl)].
    Leber, Magen, Darm, 1973, Volume: 3, Issue:6

    Topics: Ammonia; Blood; Blood Coagulation Disorders; Blood Viscosity; Disseminated Intravascular Coagulation; Esophageal and Gastric Varices; Ferritins; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis

1973
[Study of the kinetics of platelets and fibrinogen by radioisotopic labelling in splenomegalic cirrhosis with thrombopenia].
    Pathologie-biologie, 1972, Volume: 20, Issue:3

    Topics: Blood Platelets; Chromium Isotopes; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Iodine Isotopes; Kinetics; Liver Cirrhosis; Male; Radionuclide Imaging; Spleen; Splenomegaly; Thrombocytopenia

1972
[Case of hypofibrinogenemia with disorders of fibrin polymerization during hepatic cirrhosis].
    Pathologie-biologie, 1974, Volume: 22 suppl

    Topics: Afibrinogenemia; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Polymers

1974
[Plasma viscosity, immunoglobulins and fibrinogen in cirrhosis of the liver].
    Deutsche medizinische Wochenschrift (1946), 1972, Dec-22, Volume: 97, Issue:51

    Topics: Blood; Blood Proteins; Blood Viscosity; Collateral Circulation; Fibrinogen; Glutamate Dehydrogenase; Hepatitis; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Liver Cirrhosis; Serum Albumin

1972
[Biochemical, physiopathological and clinical aspects of platelet adhesiveness].
    Recenti progressi in medicina, 1972, Volume: 52, Issue:6

    Topics: Arteriosclerosis; Blood Coagulation; Blood Coagulation Disorders; Blood Platelet Disorders; Collagen; Diabetes Mellitus; Epinephrine; Fatty Acids; Fibrinogen; Humans; Liver Cirrhosis; Norepinephrine; Platelet Adhesiveness; Sarcoma; Serotonin; Thrombin; Trypsin; Uremia

1972
Disseminated intravascular coagulation.
    American family physician, 1973, Volume: 7, Issue:2

    Topics: Blood Cell Count; Blood Platelets; Chronic Disease; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Heparin; Humans; Liver Cirrhosis; Pregnancy; Pregnancy Complications, Hematologic; Prothrombin Time; Thrombin; Thromboplastin

1973
[Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].
    L'union medicale du Canada, 1973, Volume: 102, Issue:1

    Topics: Agglutination Tests; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Liver Cirrhosis; Neoplasms; Staphylococcus

1973
The clinical significance of the plasminogen level.
    American journal of clinical pathology, 1973, Volume: 60, Issue:2

    Topics: Adolescent; Adult; Afibrinogenemia; Blood Coagulation Tests; Contraceptives, Oral; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhagic Disorders; Humans; Infections; Liver Cirrhosis; Male; Menstruation; Middle Aged; Myocardial Infarction; Neoplasms; Plasminogen; Sex Factors; Surgical Procedures, Operative; Thrombosis; Wounds and Injuries

1973
[Plasma viscosity and portal hypertension in liver cirrhosis (author's transl)].
    Klinische Wochenschrift, 1973, Volume: 21, Issue:1

    Topics: Adult; Aged; Blood Coagulation; Blood Proteins; Blood Viscosity; Esophageal and Gastric Varices; Female; Fibrinogen; Fibrinolysis; Humans; Hypertension, Portal; Immunoglobulin G; Liver Cirrhosis; Male; Microcirculation; Middle Aged

1973
Antihaemophilic factor A (F VIII) and serum fibrin-fibrinogen degradation products in hepatic cirrhosis.
    Scandinavian journal of haematology, 1973, Volume: 11, Issue:2

    Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Factor VIII; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Humans; Liver Cirrhosis; Male; Plasminogen; Thromboplastin

1973
Complement and liver cell function in 53 patients with liver disease.
    The American journal of medicine, 1973, Volume: 55, Issue:6

    Topics: Adult; Aged; Child; Cholesterol; Complement System Proteins; Factor V; Factor VII; Factor X; Female; Fibrinogen; Glomerulonephritis; Hepatitis; Humans; Immunologic Deficiency Syndromes; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Prothrombin; Prothrombin Time; Purpura, Thrombocytopenic; Serum Albumin

1973
[Physiopathology of the process of fibrin stabilization].
    Medicina interna, 1973, Volume: 25, Issue:4

    Topics: Abortion, Septic; Anuria; Arteriosclerosis; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Factor XIII; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Leukemia; Liver Cirrhosis; Pregnancy

1973
[Decomposition products of fibrin(ogen) and collateral circulation in liver cirrhosis].
    Zeitschrift fur Gastroenterologie, 1973, Volume: 11, Issue:3

    Topics: Blood Protein Electrophoresis; Collateral Circulation; Fibrin; Fibrinogen; Humans; Immunoelectrophoresis; Immunoglobulin G; Liver Circulation; Liver Cirrhosis; Microcirculation; Thrombocytopenia

1973
[Chronic fibrinolysis in alcoholic cirrhosis].
    L'union medicale du Canada, 1974, Volume: 103, Issue:8

    Topics: Alcoholism; Blood Cell Count; Blood Platelets; Chronic Disease; Fibrinogen; Fibrinolysis; Heparin; Humans; Liver Cirrhosis; Male

1974
Fibrinolytic activity and haemagglutination inhibition immunoassays.
    Scandinavian journal of haematology, 1970, Volume: 7, Issue:4

    Topics: Adult; Aged; Biguanides; Clofibrate; Coronary Disease; Ethylestrenol; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Hemostasis; Humans; Immunoassay; Immunodiffusion; Immunoelectrophoresis; Liver Cirrhosis; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Physical Exertion; Plasminogen; Prostatic Neoplasms; Stimulation, Chemical; Time Factors; Tolazamide

1970
[Fibrinogen and fibrin degradation products (FDP) in hepatic cirrhosis].
    Sangre, 1972, Volume: 17, Issue:1

    Topics: Blood Coagulation Disorders; Fibrin; Fibrinogen; Humans; Liver Cirrhosis

1972
Platelet and fibrinogen kinetics with ( 75 Se)selenomethionine in thrombocytopenic states. II.
    British journal of haematology, 1972, Volume: 22, Issue:5

    Topics: Adrenal Cortex Hormones; Blood Coagulation; Blood Platelets; Female; Fibrinogen; Humans; Kinetics; Leukemia; Liver Cirrhosis; Lymphoma; Methionine; Selenium; Splenectomy; Thrombocytosis

1972
Specific determinations of prothrombin for evaluation of liver function.
    Acta medica Scandinavica, 1972, Volume: 191, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Alcoholic Intoxication; Antithrombins; Blood Cell Count; Blood Platelets; Blood Protein Electrophoresis; Blood Proteins; Factor IX; Factor V; Female; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Liver Function Tests; Male; Prothrombin; Sex Factors

1972
Plasma protein pattern in cirrhosis of the liver.
    Scandinavian journal of clinical and laboratory investigation. Supplementum, 1972, Volume: 124

    Topics: Adult; Aged; Alcoholism; Blood Proteins; C-Reactive Protein; Female; Fibrinogen; Glycoproteins; Haptoglobins; Humans; Immunoelectrophoresis; Liver Cirrhosis; Male; Middle Aged; Mucoproteins; Trypsin Inhibitors

1972
[Blood coagulation disorder in liver cirrhosis. Clinical and clinicochemical observations].
    Medizinische Klinik, 1972, Apr-21, Volume: 67, Issue:16

    Topics: Adult; Aged; Ammonia; Blood Cell Count; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Esophageal and Gastric Varices; Female; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Portography; Prothrombin Time; Radionuclide Imaging; Thrombelastography; Thrombocytopenia

1972
[Blood coagulation changes in splenic diseases].
    Vestnik khirurgii imeni I. I. Grekova, 1972, Volume: 108, Issue:4

    Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Dogs; Fibrinogen; Fibrinolysis; Heparin; Humans; Leukocyte Count; Liver Cirrhosis; Prothrombin; Spleen; Splenectomy; Splenic Diseases; Splenic Infarction; Splenic Rupture; Splenic Vein; Splenomegaly; Thrombosis; Time Factors; Tissue Extracts

1972
Detection of fibrinogen-fibrin degradation products by counterelectrophoresis.
    Journal of clinical pathology, 1972, Volume: 25, Issue:9

    Topics: Blood Coagulation Tests; Contraceptives, Oral; Female; Fibrin; Fibrinogen; Humans; Immunoelectrophoresis; Liver Cirrhosis; Methods; Neoplasms; Postoperative Complications; Precipitin Tests; Sepsis; Thrombin

1972
Metabolism of fibrinogen in cirrhosis of the liver.
    Southern medical journal, 1971, Volume: 64, Issue:10

    Topics: Adult; Aged; Blood Coagulation Disorders; Computers; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysis; Half-Life; Heparin; Humans; Immunoelectrophoresis; Iodine Isotopes; Liver Cirrhosis; Male; Middle Aged; Plasma Volume; Statistics as Topic

1971
[Half life determination of 131 I marked fibrinogen on patients with liver cirrhosis and esophageal varices].
    Die Medizinische Welt, 1971, Oct-22, Volume: 43

    Topics: Esophageal and Gastric Varices; Fibrinogen; Half-Life; Humans; Iodine Radioisotopes; Liver Cirrhosis; Time

1971
The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases.
    Journal of clinical pathology, 1971, Volume: 24, Issue:9

    Topics: Adult; Aged; Female; Fibrinogen; Fibrinolysis; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Metastasis; Plasminogen

1971
Metabolism of fibrinogen in cirrhosis of the liver.
    The Journal of clinical investigation, 1971, Volume: 50, Issue:8

    Topics: Adult; Blood Coagulation Disorders; Computers; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysis; Half-Life; Heparin; Humans; Immunoelectrophoresis; Iodine Isotopes; Liver Cirrhosis; Male; Middle Aged; Plasma Volume; Statistics as Topic

1971
[Hemagglutination inhibition (Merskey's test) in consumption coagulopathies. Apropos of 101 patients].
    La Presse medicale, 1971, May-01, Volume: 79, Issue:22

    Topics: Abortion, Septic; Asparaginase; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Extracorporeal Circulation; Female; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Humans; Leukemia, Myeloid, Acute; Liver Cirrhosis; Pregnancy; Streptokinase

1971
[Some indices of the blood coagulation system in patients with liver cirrhosis before and after surgery].
    Klinicheskaia khirurgiia, 1966, Volume: 5

    Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrinogen; Gastrointestinal Hemorrhage; Hepatitis A; Humans; Liver Cirrhosis; Male; Splenomegaly

1966
Proteinase inhibitors in portasystemic shunts.
    Annals of the New York Academy of Sciences, 1968, Jun-28, Volume: 146, Issue:2

    Topics: Aminocaproates; Aprotinin; Blood Coagulation Disorders; Blood Transfusion; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver Cirrhosis; Portal System; Postoperative Complications; Time Factors

1968
Eight years of experience with massive blood transfusions.
    The Journal of trauma, 1971, Volume: 11, Issue:4

    Topics: Abdominal Injuries; Adolescent; Adult; Age Factors; Aneurysm; Blood Coagulation Disorders; Blood Group Incompatibility; Blood Platelet Disorders; Blood Transfusion; Child; Coombs Test; Factor V Deficiency; Factor VIII; Fibrinogen; Gastrointestinal Hemorrhage; Hemorrhage; Homeostasis; Humans; Infections; Liver Cirrhosis; Middle Aged; Neoplasms; Pancreatitis; Prothrombin Time; Retrospective Studies; Rupture; Shock; Vascular Diseases; Wounds and Injuries

1971
Fibrinolysis at rest and after exercise in hepatic cirrhosis.
    British journal of haematology, 1969, Volume: 17, Issue:5

    Topics: Adult; Aged; Female; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Liver Cirrhosis; Male; Middle Aged; Physical Exertion; Plasminogen; Serum Globulins

1969
Plasma fibrin-stabilizing factor: acquired deficiency in various disorders.
    American journal of clinical pathology, 1969, Volume: 52, Issue:5

    Topics: Acute Disease; Adult; Aged; Anemia, Macrocytic; Anemia, Sickle Cell; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Disease; Cysteine; Factor XIII; Fibrinogen; Hepatitis; Hot Temperature; Humans; Leukemia; Liver Cirrhosis; Liver Neoplasms; Lupus Erythematosus, Systemic; Lymphoma; Methods; Middle Aged; Myeloproliferative Disorders; Neoplasm Metastasis; Prothrombin Time; Uremia

1969
Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
    Scandinavian journal of haematology, 1969, Volume: 6, Issue:6

    Topics: Adolescent; Adult; Aged; Aminocaproates; Anticholesteremic Agents; Arteriosclerosis; Arthritis, Rheumatoid; Asthma; Clofibrate; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Immunoassay; Intermittent Claudication; Kidney Failure, Chronic; Liver Cirrhosis; Lung Neoplasms; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Phlebitis; Physical Exertion; Plasminogen; Primary Myelofibrosis; Propionates; Pulmonary Heart Disease; Testosterone; Tolazamide; Urea

1969
Augmentation of albumin but not fibrinogen synthesis by corticosteroids in patients with hepatocellular disease.
    The Journal of clinical investigation, 1970, Volume: 49, Issue:12

    Topics: Adult; Albumins; Body Weight; Carbon Isotopes; Chronic Disease; Female; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Male; Middle Aged; Plasma Volume; Prednisolone; Serum Albumin

1970
Simultaneous fibrinogen and platelet survival with (75Se)selenomethionine in man. Studies in diseases with normal coagulation and in hepatocellular disease with abnormal coagulation.
    British journal of haematology, 1970, Volume: 18, Issue:3

    Topics: Blood Cell Count; Blood Coagulation Disorders; Blood Platelets; Fibrinogen; Fibrinolysis; Hemolysis; Humans; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Radioisotopes; Selenium

1970
Mechanisms of acquired defects of the stabilization of fibrin.
    British journal of haematology, 1971, Volume: 20, Issue:4

    Topics: Adsorption; Aluminum Silicates; Blood Coagulation Disorders; Dialysis; Factor XIII; Fibrinogen; Hot Temperature; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Liver Diseases; Necrosis

1971
Fibrinogen degradation products.
    The New England journal of medicine, 1971, Jun-24, Volume: 284, Issue:25

    Topics: Cerebrovascular Disorders; Disseminated Intravascular Coagulation; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Liver Cirrhosis; Myocardial Infarction; Neoplasms; Pulmonary Embolism; Vascular Diseases

1971
[On the problem of atherosclerosis in liver cirrhosis].
    Kardiologiia, 1967, Volume: 7, Issue:4

    Topics: Adult; Aged; Arteriosclerosis; Blood Coagulation Tests; Cholesterol; Coronary Disease; Fibrinogen; Fibrinolysis; Heparin; Humans; Lipid Metabolism; Liver Cirrhosis; Middle Aged; Phospholipids; Thrombelastography

1967
[Coagulation studies in liver diseases of children].
    Zeitschrift fur Kinderheilkunde, 1968, Volume: 103, Issue:4

    Topics: Adolescent; Alkaline Phosphatase; Bile Ducts; Bilirubin; Blood Coagulation Tests; Child; Child, Preschool; Factor V; Factor VII; Factor X; Fibrinogen; Gallbladder Diseases; Hepatitis A; Hepatolenticular Degeneration; Humans; Infant; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Transaminases

1968
Urokinase therapy in pulmonary thromboembolism.
    American heart journal, 1968, Volume: 76, Issue:5

    Topics: Adult; Aged; Angiography; Arteriosclerosis; Blood Coagulation Tests; Brain Diseases; Breast Neoplasms; Fibrinogen; Fibrinolytic Agents; Humans; Liver Cirrhosis; Middle Aged; Obesity; Phlebitis; Plasminogen; Prothrombin Time; Pulmonary Embolism; Radionuclide Imaging; Schizophrenia; Thromboembolism

1968
Studies on fibrinolysis in patients with Banti's syndrome.
    The Kumamoto medical journal, 1968, Jun-30, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Female; Fibrinogen; Fibrinolysis; Humans; Hypersplenism; Liver; Liver Cirrhosis; Male; Middle Aged; Plasminogen; Spleen; Splenectomy

1968
[Paper and agar electrophoresis results of pathologic plasma proteins with specific reference to fibrinogens].
    Die Medizinische Welt, 1968, May-11, Volume: 19

    Topics: Blood Protein Disorders; Blood Protein Electrophoresis; Fibrinogen; Hepatitis A; Humans; Immunoelectrophoresis; Liver Cirrhosis; Neoplasms

1968
[The state of the blood coagulation system in children with cirrhosis of the liver].
    Pediatriia, 1968, Volume: 47, Issue:2

    Topics: Adolescent; Blood Coagulation; Child; Child, Preschool; Fatty Liver; Fibrinogen; Humans; Infant; Liver Cirrhosis; Prothrombin

1968
Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
    Thrombosis et diathesis haemorrhagica, 1969, Feb-28, Volume: 21, Issue:1

    Topics: Acetates; Adolescent; Adult; Age Factors; Aged; Blood Coagulation Factors; Calcium; Factor XIII; Female; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Thrombin; Time Factors

1969
Coagulation factors in human lymph and plasma.
    The American journal of the medical sciences, 1965, Volume: 250, Issue:3

    Topics: Anticoagulants; Antithrombins; Blood Coagulation Factors; Factor V; Factor VIII; Fibrinogen; Humans; Liver Cirrhosis; Lung Neoplasms; Lymph; Pancreatitis; Prothrombin; Thoracic Duct

1965
[Severe fibrinolytic hemorrhage after bilateral ligation of the external iliac vein].
    Wiener klinische Wochenschrift, 1965, Sep-03, Volume: 77, Issue:35

    Topics: Blood Coagulation Disorders; Blood Transfusion; Caproates; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Iliac Vein; Liver Cirrhosis; Mitral Valve Insufficiency

1965
[Haptoglobin in hepatic cirrhosis].
    Bollettino della Societa italiana di biologia sperimentale, 1964, Nov-15, Volume: 40, Issue:21

    Topics: Blood Protein Electrophoresis; Fibrinogen; Haptoglobins; Humans; Liver Cirrhosis; Prothrombin Time

1964
Evaluation of fibrinolysis in hepatic cirrhosis. Relation of serial thrombin time and euglobulin lysis time.
    American journal of clinical pathology, 1966, Volume: 45, Issue:1

    Topics: Aminocaproates; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; In Vitro Techniques; Injections, Intravenous; Liver Cirrhosis; Nicotinic Acids; Statistics as Topic

1966
Age and disease-related alterations in fibrinogen-euglobulin (fibrinolytic) behavior.
    The American journal of the medical sciences, 1966, Volume: 251, Issue:5

    Topics: Adult; Aged; Aging; Blood; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Male; Middle Aged; Serum Globulins

1966
Turnover of 131-I-labelled fibrinogen in man. Studies in normal subjects, in congenital coagulation factor deficiency states, in liver cirrhosis, in polycythemia vera and in epidermolysis bullosa.
    Acta medica Scandinavica, 1966, Volume: 179, Issue:5

    Topics: Adolescent; Adult; Blood Coagulation Disorders; Epidermolysis Bullosa; Female; Fibrinogen; Humans; In Vitro Techniques; Iodine Isotopes; Liver Cirrhosis; Male; Middle Aged; Polycythemia Vera

1966